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ABSTRACT 
Engineered nanomaterials (ENMs) exhibit unique electronic and optical properties, which 
are suitable for the broad spectrum of applications including biomedical, aerospace, 
textiles, agriculture. Such unique properties of ENMs also raise significant concerns over 
their adverse ecological and physiological effects. In the past two decades, ENMs were 
found to exhibit complex interactions in biological milieu. It is expected that 
physicochemical properties of ENMs and their surrounding environment influence their 
environmental and physiological fate and transport. Indeed, a comprehensive 
understanding of interactions at the nano-bio interface is critical to designing 
environmentally and physiologically benign ENMs pivotal to the future growth of 
nanomedicine and its applications. To this end, the present work experimentally 
investigates nanomaterial-biomolecular corona (or biocorona) using spectroscopic 
techniques and biological assays. Specifically, the influence of defects, surface 
functionalization, and physiological environment on the formation of biocorona and 
ensuing biological responses is presented.  
The first two chapters (Chapters 1 and 2) provide a succinct introduction to 
nanotoxicity with focus on biocorona formation and various spectroscopic 
characterization techniques utilized. In Chapter 3, the variation in biocorona formation 
due to defects in the structure of single-walled and multi-walled carbon nanotubes 
(SWCNTs and MWCNTs) is presented. Briefly, it was found that defects result in 
significant changes in the nature and amount of proteins adsorbed on SWCNTs due to 
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differences in their charge distribution. In case of MWCNTs, carboxylated MWCNTs 
with higher density of defects resulted in a stronger binding and efficient delivery of 
antigens. In Chapter 4, a unique study exploring the effect of diseased (hyperlipidemic) 
physiological state on the biocorona composition (instead of the normal healthy state) is 
presented. Our findings suggest that disease-induced variations in the physiological 
environment have a significant impact on nanomaterial-biomolecular corona, cell 
response, and cellular association.  
In Chapter 5 provides new spectroscopic insights into charge transfer interactions 
between biomolecules (aromatic amino acid complexes) and emerging two-dimensional 
(2D) ENMs like graphene, graphene oxide, and BN. The adsorption of amino acids on 
2D materials was observed to considerably alter their biological response in terms of 
generation of reactive oxygen species. Also, the influence of different surface functional 
groups on Ag nanoparticles on conformational changes in apolipoprotein biocorona and 
ensuing biological is explored. Finally, Chapter 6 explores environmental effects of 
graphene, BN upon their interaction with natural organic matter (NOM).  The results 
show that the delocalized -electron cloud in graphene facilitated a significant charge 
transfer and chemisorption of NOM unlike BN. Also, BN was found to result in algal cell 
rupture and reduction in photosynthetic activity unlike graphene. 
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In the past decade, nanomaterial-based products found their way to consumer 
stores translating nanotechnology from bench to bedside. Nanotechnology impacted 
several industries including energy, medical, sports, electronics, agriculture, and textiles. 
Vance et al.[3] reported a thirty-fold increase in a number of nano engineered products 
between 2005 and 2015. Among fast-growing metal nanoparticles applications, silver 
takes a major share of 24% in the market. Therefore, human and environmental exposure 
to nanomaterials is inevitable. Despite the broad range of nanomaterial applications, its 
use is limited owing to its potential risks to the environment and human population.  
Nanotoxicity is a field of research dedicated to understanding potential risks 
associated with the use of engineered nanomaterials (ENMs) to both humans and 
environment. Although concerted research efforts led to an initial assessment of 
nanomaterial toxicity in the last decade, there has been a lack of fundamental 
understanding of nano-bio interactions in terms biomoelcular adsorption or biocorona. To 
impress the relevance of this research interest, a database query on PubMed with 
‘nanoparticle AND corona’ in search criteria yielded ~1000 entries as shown in Fig. 
1.1.1. The trend shows a three-fold increase in a number of reports since 2012, which 





Figure 1.1.1: PubMed entries to search criteria ‘nanoparticle AND corona’ since 2000. 
 
This chapter briefly describes the transport and fate of ENMs in our ecosystem 
and reviews findings in the literature exploring nanomaterials toxicity and its influential 
factors. The inadvertent fouling of ENMs by biomolecules provides a biological identity, 
which could potentially trigger undesired physiological responses. The following sections 
discuss various physicochemical properties of ENMs, which dictate the formation and 
composition of nanomaterial-biomolecular corona or boicorona and in turn their 
toxicological effects on physiology and environment. 
 
1.1 Nanomaterial-biomolecular corona (or biocorona) 
 
Global research efforts have led to a better understanding of nanomaterial 
toxicity. Yet, the fundamental mechanisms through which nano–bio interactions occur 
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still remain largely inconclusive.[4] Building on the understanding of adsorbed 
biomolecules in cellular responses to biomaterials, a new picture of nanotoxicity based on 
protein-nanomaterial interactions is recently beginning to emerge.[5]–[7] Upon their 
introduction to any physiological environment, the surface of nanomaterials gets coated 
with various biomolecules including proteins, peptides, and lipids collectively referred to 
as the nanomaterial-biomolecular corona or biocorona. Interestingly, it is the biocorona 
that dictates the fate of nanomaterials in any biological medium rather than the bare 
nanomaterial itself.  
Biocorona is formed due to the high surface free energy of ENMs, leading to 
adsorption of many biomolecules, most prominently proteins in order to reduce surface 
free energy. Although at the initial stage most abundant proteins present in the 
physiological medium adsorb onto the ENM surface, these proteins will be swapped by 
proteins with higher affinity over time (Vroman’s effect [8]). The adsorption process is 
governed by protein-protein interactions as well as protein affinities for the ENMsurface. 
As shown in the schematic Fig 1.1.2 proteins with higher binding affinities form “hard” 
biocorona and low binding affinity proteins form the “soft” biocorona. Hard biocorona 
proteins is known to interact with ENM surface through van der Walls interactions, 
hydrogen bonds, electrostatic interactions, and hydrophobic interactions whereas soft 
biocorona proteins interact via weak protein-protein interactions. These hard and soft 
layers are also distinguishable depending on the exchange rates. While the soft layer is 






Figure 1.1.2: Depending on protein affinity for nanoparticle surface two distinguishable 
layers (hard and soft) are formed as shown in this schematic. The complexity of 
biocorona composition (both hard and soft corona) due to the availability of various 
proteins is illustrated with different colors and shapes here. Modified with permission 
from ref [2].  
 
The nature (structure and composition) of the biocorona is found to be complex 
and unique for all nanomaterials dependent on several parameters such as nature of the 
physiological environment, exposure time, and physicochemical properties of ENMs 
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(composition, size, shape, surface charges, surface functional groups). It is also known 
that adsorbed proteins in biocorona may undergo structural rearrangement or 
conformational changes, which could alter protein interaction with other biomolecules. 
Nanoparticle composition and its surface chemistry are also found to be key in 
identifying binding proteins and their affinities. Hence, a thorough understanding of all 
factors is critical for the safe design of nanomaterials.  
 
1.2 Relation to physicochemical properties of nanomaterials and its environment 
 
ENMs exhibit optical, electrical, magnetic, and mechanical properties distinct 
from their bulk counterparts. Due to their small size, ENMs can easily cross biological 
barriers (e.g., blood-brain barrier) and could cause undesired biological implications. 
Broadly speaking, all factors affecting nano-bio interactions could be categorized under 
physicochemical properties of ENMs and the exposed environment as shown in Fig. 
1.2.1.[1] These parameters have also been reviewed by other research groups.[6], [10]–
[12] Table 1.2.1 summarizes the findings for various nanoparticle properties. In this 





Fig 1.2.1: Important factors affecting the formation of biocorona classified under 
nanoparticle properties and its surrounding environment. 
 
Tables 1.2.1: Effect of various nanoparticle (NP) properties on biocorona. Reproduced 
with permission from Nguyen et al. [1] 
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Surface curvature of nanoparticles (NPs) has been observed to affect the strength 
of protein-protein interactions. Significant changes in composition and organization of 
proteins in biocorona is also observed when nanoparticle size is comparable to the size of 
the protein.[6] Size and curvature of NPs also seem to affect binding of proteins. For 
instance, higher surface to volume ratio in gold nanomaterials of 30 nm diameter 
adsorbed more proteins than 50 nm sized nanoparticles as reported by Dobrovolskaia et 
al.[13] Proteins on gold nanoparticles were observed to by structurally changed 
(unfolded) and indeed catalyze the formation of protein aggregates.  
In addition to size and shape, defects that are inevitable in ENMs also play a role 
in biocorona formation needs attention. Chapter 4 presents variations in biocorona due to 
defects in carbon nanotubes in detail. Hydrophobic surfaces have been found to adsorb 
more proteins compared to hydrophilic/ neutral surfaces. Proteins on hydrophobic ENMs 
tend to unfold in order to accommodate more proteins. Albumin molecules have been 
shown to adsorb more proteins on hydrophobic nanoparticles than hydrophilic 
counterpart albeit protein affinity roughly remaining the same.[14] 
Time evolution of biocorona on different sized (4-40 nm) gold nanoparticles was 
carefully assessed by Casals and his group[15]. They stabilized these gold nanoparticles 
by coating citrate, mercaptoundecanoic for negative surface charge and 
aminoundecanethiol for a positive surface charge. NPs were exposed to cell culture 
medium containing 10% fetal bovine serum (FBS). Also they observed irreversible 
change in proteins over time, which confirm our present understanding. It has been 
reported that protein adsorption increases with increase in surface charge of NPs.[16] 
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Chapter 5 discusses Ag NPs (with various surface functional groups) and their interaction 
with apolipoprotein to form corona. 
Biological environment also plays a crucial role in coronal composition and 
formation. Maiorano et al. experiments with citrate coated Au NPs with various cell 
culture media determined how media composition influences NP-biomolecular corona 
and cellular response.[17] They chose two widely used cell culture mediums DMEM and 
RPMI with fetal bovine serum as the protein source. Biological impacts were evaluated 
with several viability assays onto cell lines human epithelial cervical cancer (HeLa) and 
human leukemic monocyte lymphoma (U937). Interestingly, they observed DMEM 
induced stable and a protein-rich corona as compared to RPMI. This study confirmed 
nanoparticle-protein complex formation mediated in physiological environment can 
impact on cellular responses. 
 
In summary, ENMs are useful for various applications including nanomedicine 
due to their unique properties. However, a deeper understanding of ENM-induced 
cytotoxic and inflammatory responses is needed before the viability of ENMs can be 
realized. To this end, it is imperative to understand the dependence of ENM-biocorona on 
ENM physicochemical properties including size, shape and surface functionality. This is 
highly complex because all the physicochemical properties are interrelated. As it will be 
discussed in the following chapters of this work, size, shape, surface charge, and defects 
are important in the formation and evolution of ENM-biocorona while biocorona 
formation itself can alter the charge and dispersion stability of the ENM system. The 
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complex interdependence between biorocona and ENM physicochemical properties is 
very hard to decouple in reality and is a major roadblock in the ability to predict ENM’s 









SPECTROSCOPIC CHARACTERIZATION TECHNIQUES 
 
The advancement of nanotechnology over the past two decades has spurred the 
fields of health care, information technology, energy, homeland security, food safety and 
transportation; and the global market for nanotechnology-related products reached more 
than $200 billion in 2009 with a projected $1 trillion per annum by 2015 (US Senate 
Committee, 2011).[18] Despite this enormous global market, there remain several 
concerns regarding the impact of engineered nanomaterials (ENMs) on biological 
responses in living organisms, and the environment at large.[19]–[23] A comprehensive 
knowledge of the ENM-biomolecular interactions is central to applications in 
nanomedicine, consumer goods, and other unintentional exposures.  Currently, there are 
more than 40 nanopharmaceuticals in routine clinical use and the patents and publications 
on nanomedicine have been exponentially increasing.[24] Considering that nanomedicine 
efforts are a sudden convergence of contrasting scientific disciplines (e.g. viz., materials 
science, bioengineering, pharmacology), the advancement and acceptance of 
nanotechnology relies heavily on a holistic interdisciplinary understanding of the impact 
of fundamental properties of ENMs (such as their morphology, size, defects and chemical 




Upon introduction into a biological system, ENMs rapidly associate a variety of 
macromolecules including proteins, peptides, amino acids, fatty acids, lipids and other 
organic matter forming protein biocorona. [25]–[27] The formation of the corona is not 
only dictated by the physicochemical properties of the ENM but also the composition of 
the physiological environment. [28] The addition of the corona on the surface of the 
ENM imparts a new distinctive interactive surface, which influences activity, deposition, 
clearance, and cytotoxicity. [29]–[31] The biocorona has also been shown to compromise 
the targeting capacity of functionalized ENMs and subsequently hinder delivery therapy. 
[27], [32], [33]  In addition, the inconsistencies observed between in vitro to in vivo 
extrapolation of ENM toxicity are likely contributable to differences in ENM-biocorona 
formation. [25], [34] Spectroscopic tools are ideal for exploring the biological 
interactions of ENMs with proteins.[6], [35], [10] As discussed in this chapter, combining 
spectroscopic tools with traditional toxicological studies can provide unique insights into 
the nano-bio interface that could be used to ultimately design benign ENMs. 
 
2.1 Hyperspectral imaging 
 
Gold and silver nanoparticles display a collective and resonant oscillation of 
surface electrons, known as plasmons, upon light excitation in the visible region (400-700 
nm).  The surface plasmon resonance is highly sensitive to both nanoparticles 
aggregation and the dielectric constant of the environment surrounding them. In a 
biological medium, the presence of protein corona around nanoparticles alters the SPR 
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peak by modifying the dielectric constant. [36] Similarly, their cellular uptake could lead 
to aggregation, which is known to red-shift the SPR peak. [37] Hyperspectral imaging is 
an excellent tool that combines microscopy and spectroscopy in real time by 
accumulating reflectance spectrum for each pixel in a micrograph.  Thus, the state of 
nanoparticles and protein corona upon cellular uptake can be gleaned from the 
hyperspectral micrographs.[38]–[40] Recently, we explored the cellular uptake of silver 
nanoparticles (Ag NPs) with and without protein corona using hyperspectral imaging.[41] 
Our studies revealed intracellular modifications resulting from protein corona formation 
as shown in Fig. 2.1.1. Changes in the microenvironment of AgNPs were evidently 
reflected in the shift of plasmon energies allowing us to differentiate between intra- and 
extra-cellular nanoparticles. Hyperspectral imaging presents an alternative to traditional 
electron microscopy methods for the identification of nanoparticles and protein corona 
inside the cell. [42]–[45]The exhaustive sample preparation needed for electron 
microscopy, such as encapsulation in a polymer followed by microtoming, often leads to 
artifacts. For example, the large agglomerates formed during the electron microscopy 
sample preparation are indistinguishable from agglomerates resulting from the loss of 





Figure 2.1.1: (a) Hyperspectral enhanced darkfield images of macrophages exposed to 
AgNPs and AgNPs with protein corona for 2 h, at a concentration of 25μg/mL. 
Macrophage nucleus appears blue in the images due to DAPI stain. (b) Differences in 
mean spectra for AgNPs with different sizes (20 and 110 nm) and coatings (PVP and 
citrate). Based on such shifts in plasmon energies, it is possible to study the uptake and 
modification of AgNPs using hyperspectral imaging. 
 
2.2 Circular dichroism spectroscopy 
 
ENM-protein complex formation poses concerns on potential denaturation of 
proteins, which can alter protein binding to receptors and induce inflammatory responses.  
Lysozyme, for example, adsorbed on gold nanoparticles (AuNPs) were observed to 
induce misfolded proteins which likely catalyze the formation of aggregates.[46] 
Similarly, fibrinogen was found to unfold on the surface of stabilized (negatively charged 
with polyacrylic acid) AuNPs, and bind to integrin receptor (MAC-I) leading to the 
inflammatory response.[47] Circular dichroism (CD) spectroscopy has been extensively 
used to study conformational changes in biomolecules.[48]–[50] CD studies on ENM 
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protein corona can elucidate the changes in protein secondary structures ensuing from 
their adsorption to ENMs surface.[51] For example, apolipoprotein (ApoA-I) protein, 
which is known to be abundant in the protein corona of metal nanoparticles, exhibited 
secondary structural changes dependent on the surface coating (Fig. 2.2.1). ApoA-I is the 
major lipoprotein component of high-density lipoprotein (HDL). It adopts a shape similar 
to a horseshoe of dimensions 12.5x8x4 nm with high α-helix content.[52]–[54] The 
helices in ApoA-I are predicted to be amphipathic, with the hydrophobic (/hydrophilic) 
face mediating lipid (/aqueous) interactions. The thermodynamic drive to minimize the 
aqueous exposure of the hydrophobic residues is one of the major factors in ApoA-I 
adsorption on AgNPs.[55], [56] We studied the interactions between ApoA-I and 100 nm 
AgNPs with four different coatings viz., citrate, polyvinylpyrrolidone (PVP), branched 
polyethyleneimine (bPEI) and lipoic acid.[57] These coatings were chosen to provide 
both negative (citrate, PVP, lipoic acid) and positive charged surfaces (bPEI) with 
different affinities for AgNPs. While lipoic acid interacts strongly through Ag-S bonds, 
other coatings (citrate, PVP, bPEI) are considerably weaker. As shown in Fig. 2.2.1, CD 
studies showed a significant decrease in α-helical content for all surface coatings with the 
complete disappearance of α−helices for AgNP-bPEI and AgNP-lipoic acid. From a 
physiological standpoint, we found a significant increase in the ability of ApoA-I coated 
AgNP-bPEI and AgNP-lipoic acid to generate reactive oxygen species due to its 
unfolding. The conformational changes observed in CD can provide more information on 





Figure 2.2.1: (a) Circular dichroism (CD) spectra for ApoA-I incubated with AgNPs of 
different surface coatings (citrate, PVP, bPEI, and lipoic acid) shows (b) marked decrease 
in α-helix content with corresponding increase in β-sheets and irregular structures. 
Spectra were analyzed using CAPITO (a CD Analysis & Plotting Tool) and secondary 
structure content was estimated. CD spectroscopy provides secondary and tertiary protein 
structure content estimation of biomolecules, which is critical for analyzing 
conformational changes during ENM-protein interactions. 
 
2.3 Infrared spectroscopy 
 
Unlike metal nanoparticles, carbon-based ENMs exhibit strong optical absorption 
<240 nm due to their π-electron system, which can interfere with protein CD spectra 
collected in 200-300 nm range, precluding the use of CD to study nanocarbon-protein 
corona. Alternatively, we used ATR-FTIR (attenuated total internal reflection- Fourier 
transform infrared) spectroscopy to elucidate the adsorption-induced structural changes in 
proteins (bovine serum albumin or BSA and fibrinogen) on carbon ENMs such as multi-
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walled carbon nanotubes (MWNTs), graphene and graphene oxide nanoribbons (GNRs 
and GONRs). The FTIR spectrum of proteins displays two main bands, Amide I (1600-
1700 cm-1) and Amide II (1500-1580 cm-1), arising from the amide bonds that link the 
amino acids in proteins. While Amide I band is mainly associated with the C=O 
stretching vibration, Amide II band results primarily from bending vibrations of the N—
H bond. Given that both the C=O and the N—H bonds are involved in the hydrogen 
bonding between the different peptide units, their spectral position and intensity can be 
used to determine the secondary structure content of a protein. For example, as shown in 
Fig. 2.3.1, the α-helical content in BSA leads to strong adsorption ~1640-1660 cm-1 
(dashed lines) while the lower frequency component at ~1620-1640 cm-1 and the peak 
~1555 cm-1 arise from β-sheets. Clearly, the rich secondary structure of BSA 
(particularly, the peak relating to α-helical content) significantly disappears upon its 
adsorption on to all carbon-based NMs, as expected from its low internal stability. 
Indeed, the changes in secondary structure are higher in the case of MWNTs (i.e., 
complete disappearance of secondary structure) suggesting that BSA unfolds much more, 
relative to GNRs and GONRs, in order to adhere to the tubular MWNTs. GNR and 
GONR retain BSA secondary structure to a certain extent, as shown by the presence of 
~1555 cm-1 for β-sheets. In the case of fibrinogen, the secondary structural changes are 
found to be higher for GONRs compared to MWNTs and GNRs plausibly due to the 
formation of hydrogen bonds. The α-helix peak was found to partially disappear for 
fibrinogen adsorbed on MWNTs and GNRs. Lastly, the structural changes for fibrinogen 
on GNRs seemed to be less pronounced than MWNTs possibly due to its shape. It could 
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be rationalized that fibrinogen must unfold more to adhere to MWNTs due to their higher 
curvature than GNRs. To further understand NM-BSA interactions, we also performed 
large-scale molecular dynamics (MD) simulations of BSA-MWNT, GNR/GONR-water 
systems (detailed in [58]). As shown in Fig. 2.3.1, we observed that proteins undergo 
conformational changes after initial contact (in accordance with our experimental 
observations, discussed in Fig. 2.4.1) leading to some protein regions collapsing on to the 
ENM surface rather than gradually spreading from the initial region of contact. 
 
 
Figure 2.3.1: (a-c) Snapshots of MD simulations showing BSA on SWNT, GNR, and 
GONR 10 ns after adsorption. (d-f) show the top-view. The adsorption is accompanied by 





2.4 Electrochemical impedance spectroscopy 
 
Charge transfer is known to play an important role in several many physiological 
processes including blood clotting, vitamin absorption, and oxidative stress.[59]–[61]  
Differences in electronegativity between proteins and the ENM surface may induce 
charge transfer which, along with other perturbations in the media (e.g. pH, 
thermodynamic fluctuations), plays a critical role in protein denaturation, protein-protein 
interactions, and alterations to the cellular and extracellular redox status.  Such 
interactions are not necessarily specific, with conformational changes possibly resulting 
in newly exposed charged regions and hydrophobic domains attracting or repelling other 
surrounding proteins or nanostructures. Electronic properties of ENMs including their 
band structure and density of states have been shown to regulate protein adsorption 
dynamics via charge transfer, which is evident as shifts in absorption and emission 
spectra.[62], [63] 
 
2.4.1 Charge transfer during corona formation  
 
The chemisorption of proteins on bulk material surfaces has been known to occur 
through charge transfer processes. For example, the aromatic amino acids present in BSA 
(tryptophan, phenylalanine, histidine, and tyrosine) could interact with the unhybridized 
pz orbitals of the carbon-based ENMs, via providing a weak acceptor level in the 
electronic density of states (DOS) to allow partial charge transfer. It may be expected that 
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a surface facilitating higher charge transfer at the nanoscale may lead to stronger surface-
protein interactions and a subsequent increase in protein adsorption. Spectroscopic and 
electrochemical techniques such as micro-Raman, CD, and cyclic voltammetry can be 
used to analyze elucidate the influence of charge transfer on protein affinity for ENMs 
and the alterations in secondary and tertiary structures that occur with adsorption. Among 
the variety of ENMs, nanocarbons possess a strong affinity for proteins through 
hydrophobic and aromatic π-π stacking interactions. [64] Previously, we elucidated the 
charge transfer interactions between nanocarbons and proteins using micro-Raman 
spectroscopy. Our results show strong interactions of proteins (albumin and fibrinogen) 
with nanocarbons is strongly influenced by charge transfer between them, inducing 
protein unfolding which enhances conformational entropy and higher protein adsorption. 
For instance, the UV-visible absorption spectrum of single-wall carbon nanotubes 
(SWNTs) coated with BSA was found to blue shift significantly while BSA-coated 
graphene sheets (both exfoliated and synthesized via chemical vapor deposition) 
exhibited no such changes.[65] Additionally, micro-Raman spectroscopy revealed 
alterations in the structure of the G-band (or graphitic band) of BSA-coated SWNTs. The 
G-band, which is highly sensitive to charge transfer, was found to be upshifted with a 
Breit-Wigner-Fano lineshape resulting from electron transfer between BSA and SWNTs.  
No changes were observed for graphene upon protein coating indicating that ENMs-BSA 
charge transfer is unique to SWNTs.  Concomitantly, FTIR spectroscopy revealed 
subsequent conformational changes in BSA (Figure 4) in the form of unfolding of α–
helices, suggesting hard corona formation on SWNTs as opposed to graphene.  These 
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results insinuate that disruption in electrostatics due to ENM-protein charge transfer leads 
to the breaking of peripheral H-bonds in the α–helices and permanent denaturation of 
BSA on SWNTs. [65], [66] 
 
 
Figure 2.4.1: (a) FTIR spectra for native BSA, BSA-adsorbed on MWNTs, GNRs, and 
GONRs show that the CNMs significantly affected the secondary structures of the 
proteins. The absorption peak for α-helix in native BSA, in the range from 1640 to 1660 
cm-1 (indicated by the vertical dashed lines), showed a significant reduction (disappeared 
for MWNTs) for all CNMs suggesting that the secondary structure of BSA adsorbed on 
CNMs was less compact. (b) In the case of fibrinogen, the loss of secondary structure 
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was highest for GONRs possibly due to the formation of hydrogen bonds. While both 
MWNTs and GNRs exhibited a loss of α-helical content, the appearance of new peak 
~1500 cm-1 (corresponding to random motifs) in GNRs suggested a lesser degree of 
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Successful immunotherapy requires identification of target antigens, their 
efficient delivery, and subsequent interaction with the antigen-presenting cells (APCs) 
and T cells without eliciting negative regulatory immune suppression or rejection in the 
host. Recently, a variety of cancer vaccines have been developed and tested in clinical 
studies but only a few trials obtained >5-10% partial or complete response. This may be 
attributed to the failure in vaccine formulation, targeted delivery, and consequent 
activation of the immune system.[67], [68] Alternatively, antigen-coated microparticles 
(e.g. 1 to 10 μm aluminum salts) have been widely used in both human and veterinary 
vaccines to stimulate immune responses and improve the efficacy of vaccines but only 
had limited success.[69] With the rapid development of nanotechnology, researchers 
expect to build on the unique physicochemical properties of nanomaterials to provide 




Among a wide variety of nanomaterials, carbon nanotubes are one of the most 
promising candidates for drug and antigen delivery due to their unique physicochemical 
properties such as the high surface area to volume ratio and delocalized pi-electron cloud. 
For example, recent studies have utilized CNTs to successfully deliver peptides[71], 
cancer testis antigen[72], and small molecular drugs[73], in various in vitro immune cell 
lines and in vivo animal models. CNTs are inherently hydrophobic and exhibit strong 
tendency to aggregate in aqueous media, which limits their use in the biomedical 
application. Accordingly, as-produced CNTs are often modified using wet chemical 
methods for adding carboxyl and hydroxyl functionalities to improve their suspension 
stability.  Such surface modifications of CNTs are also known for reducing their toxicity 
and improving their ability to modulate the immune system[74][75]. In addition, our 
proteomics studies showed that carboxylated CNTs bind significantly more serum 
proteins in cell culture media than pristine nanotubes.[76] Further, carboxylated CNTs 
have been proposed for use in vaccine delivery due to their ability to bind protein. In 
general, it appears that carboxylation of CNTs enhances their biomedical applicability. 
However, during the process of carboxylation, surface defects are often introduced into 
the CNTs and it is currently unclear how these surface defects will impact CNTs used in 
biomedical applications such as antigen delivery for vaccines. Therefore, in this study, 




In this work, we investigate the use of carboxylated multi-walled carbon 
nanotubes (MWCNTs) with two different defect densities as a vaccine delivery vehicle to 
deliver a specific antigen to stimulate the immune response. Carboxylated MWCNTs 
were loaded with ovalbumin (OVA) and delivered to bone marrow derived macrophages. 
These macrophages were co-cultured with OVA-specific CD4+ T cells isolated from OT-
II mice for 5 days. We demonstrated that OVA was abundantly absorbed on MWCNTs 
and was efficiently delivered into macrophages without observable toxicity. Interestingly, 
MWCNTs with higher defect density showed more OVA adsorption despite their low 
surface area. We found that MWCNT-OVA complex significantly induced the secretion 
of cytokines (TNFα and IL-6) and expression of MHC class II on macrophages as 
compared to MWCNTs alone or OVA alone. Remarkably, OVA peptides were presented 
on MHC class II and subsequently stimulated the robust proliferation of CD4+ T cells 
after co-culture. In contrast, MWCNTs without OVA coating did not induce cytokine 
production, expression of MHC class II, nor CD4+ T cell proliferation. Our work 
provides strong evidence for use of MWCNTs as an antigen delivery system in vaccine 
development. 
Single walled carbon nanotubes (SWCNTs) are one-dimensional structures with 
unique optical and electronic properties relevant for many biomedical applications.[77], 
[78] Particularly, the sharp densities of electronic states at the so-called van Hove 
singularities (vHS) in SWCNTs impart strong resonant optical absorption and emission 
of visible and near-infrared light, which makes them invaluable for applications in 
photothermal therapy, multimodal imaging (e.g., Raman, fluorescence and 
 
 25 
photoacoustic), and cancer drug delivery.[79], [80] While much research has focused on 
exploiting SWCNT properties for biomedical applications, their toxicity has been well 
demonstrated. Fundamental understanding of SWCNT biological interactions and 
mechanisms of toxicity still, however, remain elusive.[81]  
In physiological environments, cells interact with the biocorona (BC), which 
consists of a layer of physi- and chemi-sorbed biomolecules (i.e. proteins, lipids, 
peptides, etc.), which inadvertently accumulate on the surface of the SWCNTs.[82]–[84] 
The addition of the BC alters not only the surface and properties of the SWCNT but may 
also modify their cellular interactions similar to what has been shown with other 
nanoparticles.[85]–[87] Ultimately this means that the BC can interfere with the 
SWCNT’s function (viz., imaging or drug delivery), and alter its biodistribution, 
clearance, and/or toxicity. It has been demonstrated that the physicochemical properties 
of nanomaterials in general influence the formation and the content of BC, however, the 
impact of structural defects have not been fully evaluated.[88], [89] The formation of BC 
on SWCNTs, however, is more fundamentally intriguing due to the presence of vHS in 
its electronic structure. 
 Previously, we showed that the vHS in SWCNTs leads to unexpected charge-
transfer interactions with proteins such as fibrinogen and could lead to undesired 
thrombosis.[65] The electronic structure of SWCNTs is highly sensitive to defects, which 
are often unintentionally introduced in SWCNTs while processing them through 
mechanical or chemical functionalization for biological applications.[90], [91] The 
presence of defects alters SWCNT biomolecular interactions through charge-transfer 
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interactions and could ultimately change the composition of BC. Understanding BC 
compositional differences due to defects in SWCNTs will allow for new avenues of 
control regarding BC formation to be explored resulting in regulation of biological 
response.  
 To enable the safe and effective use of CNTs in nanotechnologies it is essential to 
evaluate differences in the BC that forms under these increasingly prominent disease 
states. In the current evaluation of the BC, we hypothesized that the defects in SWCNTs 
will result in differential association of biomolecules forming the BC.  Additionally, we 
hypothesized that disease-associated differences in the physiological media would also 
alter BC formation.  To examine the role of defects and a high cholesterol environment 
on the formation of the SWCNT-BC we utilized a quantitative proteomics approach with 
label-free mass spectrometry. We prepared SWCNTs with different defects using a 
planetary ball-milling approach. The defects in SWCNTs were characterized using a 
comprehensive array of tools including transmission electron microscopy, Raman and 
photoluminescence spectroscopy, and gas-adsorption isotherms. We observed that 
increased ball-milling time of SWCNTs resulted in more defects introduced in the 
structure of SWCNTs.  Following incubation in normal mouse serum, quantitative label-
free mass spectrometry identified differences in the biomolecular content of the BC 
resulting from the ball-milling process.  Further, incubation in cholesterol-rich mouse 
serum resulted in the formation of unique BCs compared to SWCNTs incubated in 
normal serum. Ultimately our study demonstrates that the BC is modified due to 
physicochemical modifications in SWCNT structure induced by ball-milling and due to 
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physiological disease conditions. These alterations in the BC may result in variable 
biological responses. 
 
3.2 Materials and methods 
 
3.2.1 Preparation and characterization of MWCNT-ovalbumin complex   
Pristine MWCNTs with two different sizes were obtained from Cheap Tubes Inc, 
including MWCNT-2 (10-20 nm, 0.5-2 μm) and MWCNT-30 (10-20 nm, 10-30 μm). 
Pristine MWCNTs were carboxyl functionalized according to the previous method (17). 
Size and morphology of carboxylated MWCNTs were evaluated by transmission electron 
microscopy (TEM) using a Hitachi 7600 (Hitachi Group). Diameter and length 
measurements were performed on  100 CNTs. Ovalbumin was purchased from Sigma 
and dissolved in PBS at 1 mg/mL. To generate MWCNT-OVA complex, 200 μL of 
carboxylated MWCNT (1 mg/mL), 500 μL of ovalbumin solution (1 mg/mL) and 700 μL 
of distilled water were mixed and incubated on a rotator overnight at 4 °C. The mixture 
was centrifuged (14,000 rpm, 10 min, 4°C) and the pellets were washed twice to remove 
non-adsorbed ovalbumin. After wash, the pellets were re-suspended in distilled water at 1 
mg/mL. The hydrodynamic size and zeta potential of either MWCNT or MWCNT-OVA 
complex were determined using a Zetasizer Nano ZS (Malvern Instruments).  The surface 
area measurements were performed on a Quantachrome Autosorb iQ gas sorption 
analyzer using N2 gas.  Raman characterization of MWCNTs was performed using a 




To quantify the amount of ovalbumin bound to MWCNTs, the mixture used for 
the formation of MWCNT-OVA complex was centrifuged (14,000 rpm, 10 min, 4°C) and 
the supernatant was collected. The concentration of ovalbumin in the supernatant was 
determined by Pierce BCA protein assay, which was subtracted from the initial 
concentration of ovalbumin in the original mixture to calculate the amount of ovalbumin 
bound to MWCNT. The measurement was conducted at least three times.   
 
3.2.2 Synthesis and characterization of SWCNTs. 
SWCNTs were prepared using chemical vapor deposition.27 An MTI planetary 
ball mill was used to induce defects in SWCNTs. High-resolution transmission electron 
micrographs were obtained using Hitachi H-9600. A Renishaw InVia micro-Raman 
(coupled to 514.5 nm Ar+ laser) and Bruker IFS V/66 FT-Raman equipped with 
Nd:YAG 1064 nm was used to obtain the Raman and PL spectra of SWCNTs. The 
surface area of SWCNTs was characterized using Quantachrome Autosorb instrument. 
All the spectroscopic measurements were performed in triplicates. 
 
3.2.3 Animals and cell models 
Male C57BL/6J mice were purchased from The Jackson Laboratory (Bar Harbor, 
ME) at 8-10 weeks of age. Breeding colonies of OT-II transgenic mice were also 
acquired from The Jackson Laboratory (Bar Harbor, ME), and maintained in the animal 
facility at the University of Colorado-Anschutz Medical Campus. OT-II transgenic mice 
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express the mouse alpha-chain and beta-chain T cell receptor that pairs with the CD4+ co-
receptor and is specific for chicken ovalbumin peptides (OVA323-339). All animal 
procedures were performed with approval and in accordance with the guidelines of the 
University of Colorado-Anschutz Medical Campus Institutional Animal Care and Use 
Committee.   
Male C57BL/6J mice were sacrificed and the femur bones were collected. Bone 
marrow cells were flushed aseptically from the dissected femurs using a 25-gauge needle. 
The cells were incubated in RPMI 1640 medium supplemented with 10% fetal bovine 
serum (FBS), 100 U/mL penicillin, 100 μg/mL streptomycin, 2 mM L-glutamine, 1 mM 
sodium pyruvate, 5 μM 2-mercaptoethanol, which is referred to the complete medium. 
And the complete medium was supplemented with 10 ng/mL recombinant mouse 
macrophage-colony stimulating factor (M-CSF, R&D systems, Minneapolis, MN). The 
cells were incubated in a humidified incubator at 37 °C in 5% CO2. On Day 4, the 
medium was replaced with complete medium supplemented with 5 ng/mL M-CSF. Bone 
marrow derived macrophages were used following 7 days of culture and were found to be 
>90% macrophages by expression of F4/80 antigen using monoclonal anti-mouse PerCP-
Cyanine5.5-conjugated F4/80 antibody (eBioscience, Inc).  
On the same day when macrophages were treated with MWCNTs, OT-II 
transgenic mice were sacrificed and the spleen was collected. A single cell suspension of 
splenocytes was obtained using a tissue dissociator (Miltenyi Biotec, Inc.), and red blood 
cells were removed from the splenocytes using Mouse Erythrocyte Lysing Kit (R&D, 
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Systems). CD4+ T cells were enriched using mouse CD4+ T Cell Enrichment Column Kit 
according to the manufacturer’s procedure (R&D, Systems). 
We employed fluorescent Texas Red-conjugated ovalbumin (TR-OVA) to form 
MWCNT-TR-OVA complex to confirm the successful delivery of MWCNT-OVA 
complex into macrophages using enhanced darkfield fluorescent imaging microscopy 
(Cytoviva, Inc. Auburn, AL). Macrophages were treated with 25 μg/mL of either 
MWCNT or MWCNT-TR-OVA complex in chamber slides using the serum-free 
medium. The use of serum-free DMEM is to prevent the binding of additional serum 
proteins to either MWCNTs or MWCNT-OVA complex. Following 6 h exposure, 
macrophages were washed with PBS and fixed with 4% paraformaldehyde for 10 min at 
room temperature. The nuclei were stained with DAPI. The cells were imaged using 
enhanced darkfield fluorescent microscopy (Cytoviva). The experiments were repeated at 
least three times. 
Macrophages were treated with 25 μg/mL of either MWCNTs or MWCNT-OVA 
complex for 6 hours and were washed and incubated up to 5 days in complete medium 
supplemented with 5 ng/mL M-CSF. On Day 1, Day 3 and Day 5, the supernatants were 
collected for measurement of TNFα and IL-6 production using ELISA according to the 
manufacturer’s protocol (R&D systems). For MHC class II expression, macrophages 
were detached using 0.025% trypsin and re-suspended in staining buffer (Invitrogen). Rat 
monoclonal PE/Cy5-conjugated anti-MHC class II (PE/Cy5) antibody (Abcam) was used 
to detect MHC class II expression on macrophages using flow cytometry. Prior to 
labeling MHC class II molecules, macrophages were pre-incubated with purified anti-
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mouse CD16/CD32 mAb (BD Pharmingen) to reduce Fc receptor-mediated nonspecific 
binding. Ovalbumin was used as a positive control. The experiments were conducted 
independently on a minimum of three different batches of BMDMs.  
In order to investigate if the ovalbumin delivered by MWCNTs has the ability to 
stimulate CD4+ T cell proliferation, CFSE-labeled CD4+ T cells were co-cultured with 
macrophages loaded with MWCNT-OVA complex for 5 days. Briefly, macrophages 
were treated with 25 μg/mL of either MWCNTs or MWCNT-OVA complex in the 
serum-free medium for 6 hours, and were washed and co-cultured with CD4+ T cells 
labeled with the fluorescent dye 5,6-carboxyfluorescein diacetate succinimidyl ester 
(CFSE) (Thermo Fisher Scientific) for 5 days in the complete medium supplemented with 
5 ng/mL M-CSF. The ratio of T cells to macrophages was 2:1. After 5-day co-culture, 
both macrophages and CD4+ T cells were detached using 0.025% trypsin and re-
suspended in the staining buffer. CD4+ T cells were then immunostained with APC-
conjugated mouse anti-CD4+ antibody (eBioscience) to distinguish them from 
macrophages. The proliferation of CFSE-labeled CD4+ T cells by CFSE dilution was 
analyzed using flow cytometry (AccuriTM C6 Flow Cytometer, BD Biosciences, Ann 
Arbor, MI) and FCS Express 4 software (De Novo Software, Glendale, CA). The 
experiments were repeated at least three times.    
All graphs and statistical analysis were performed using Prism 6 software 
(GraphPad, San Diego, CA). Statistical significance was analyzed by one-way analysis of 
variance (ANOVA) with differences between groups assessed using Dunnett’s post hoc 
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tests. Differences were considered statistically significant when p < 0.05. Refer Chapter 
4.2.5 section for methods on formation and evaluation of SWCNT-biocoronas. 
 
3.3 Results and discussion 
 
3.3.1 Case of MWCNTs 
 
 
Figure 3.3.1: TEM analysis of carboxylated MWCNT-2 (A) and MWCNT-30 (B). The 
outer diameters of carboxylated MWCNT-2 and MWCNT-30 were 26 ± 5 nm and 18 ± 3 
nm, respectively. The average length of both carboxylated MWCNTs was ~500 nm. 
 
As Fig. 3.3.1 shows TEM images of two carboxylated MWCNTs in their dry 
state. The size analysis indicated that the outer diameters of carboxylated MWCNT-2 and 
MWCNT-30 were 26±5 nm and 18±3 nm, respectively, which are roughly consistent 
with the manufacturer specifications. The average length of both carboxylated MWCNTs 
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was found to be ~500 nm, which is much shorter than the manufacturer specifications. 
We surmise that the functionalization process for adding carboxyl groups resulted in the 
observed reduction in length due to breaking at the defect site.[92] Our gas sorption 
measurements showed that the MWCNT-2 and MWCNT-30 samples have surface areas 
~215 m2/g and 94 m2/g, respectively. The Raman spectra of MWCNT-2 and MWCNT-30 
showed the presence of the so-called disorder or D-band (~1350 cm-1) along with the 
characteristic graphitic or G-band (~1580 cm-1) (Fig. 3.3.2). Both the samples also 
exhibited at a higher frequency shoulder to the G-band (known as the D’ band ~1620 cm-
1) suggesting high defect densities in the samples. The ratio of D- to- G band areas (ID/IG) 
was calculated to be 0.97±0.1 and 1.37±0.2 for MWCNT-2 and MWCNT-30, 
respectively, showing that MWCNT-30 samples contain more defects.  
To understand the ability of MWCNTs to deliver ovalbumin, it is important to 
quantitatively determine the amount of ovalbumin bound to MWCNTs. The amount of 
ovalbumin bound to MWCNT-2 and MWCNT-30 was 582 ± 41 μg/mL (~0.582 mg OVA 
per 1 g CNTs, 0.271 ng OVA per cm2 of CNTs) and 1066 ± 182 μg/mL (~1.066 mg OVA 
per 1 g CNTs, 1.12 ng OVA per cm2 of CNTs), respectively. This difference may be 
rationalized in terms of higher defect density (as seen from Raman spectra in Fig. 3.3.2) 
in the case of MWCNT-30 samples. Such an observation is in agreement with our 
previous experimental and theoretical studies, which show that the defects strongly 





Figure 3.3.2: The Raman spectra of carboxylated MWCNT-2 and MWCNT-30. The D-
band (~1350 cm-1) was found along with the characteristic G-band (~1580 cm-1). Both 
MWCNTs also exhibited at a higher frequency shoulder to the G-band (known as the D’ 
band ~1620 cm-1) suggesting high defect densities in MWCNTs. The ratio of D- to- G 
band areas (ID/IG) was 0.97 and 1.37 for MWCNT-2 and MWCNT-30, respectively, 























































Figure 3.3.3: Effects of ovalbumin coating on the hydrodynamic size and zeta potential 
of MWCNTs. (A) Ovalbumin coating increased the hydrodynamic size of MWCNTs (A) 
but had little impact on the zeta potential of MWCNTs (B). (n=3, mean ± SD, * p>0.05 
comparison between MWCNTs with and without ovalbumin coating) 
 
TEM characterization showed the length of MWCNTs in a dry state, however, 
MWCNTs undergo a certain degree of agglomeration upon dispersion. We measured the 
hydrodynamic size and zeta potential of MWCNTs using dynamic light scattering (DLS). 
DLS measurement showed the similar hydrodynamic size (~200 nm) of MWCNT-2 and 
MWCNT-30 due to agglomeration (Fig. 3.3.3A). As expected, MWCNT-OVA complex 
showed a significant increase in hydrodynamic size than uncoated MWCNTs. Ovalbumin 
coating increased the size of MWCNT-30 to a greater degree than MWCNT-2 (Figure 
3A) concomitant with the amount of bound ovalbumin. In addition, though both 
MWCNT-2 and MWCNT-30 have the similar zeta potential (Fig. 3.3.3B), we found that 
ovalbumin coating slightly decreased the zeta potential of MWCNT-30 (Fig. 3.3.3B) but 
not MWCNT-2 resulting in a more negatively charged MWCNT-30. 
We used photoluminescence (PL) spectroscopy to study the effect of defects on 
the adsorption of ovalbumin on MWCNTs. The aromatic amino acid content in OVA 
absorbs light strongly at ~280 nm and emits at ~338 nm, and a standard curve was 
established in terms of the intensity of the emission peak (~338 nm) in OVA (Fig. 
3.3.4A). We observed clear differences between all MWCNT-2 and MWCNT-30 
samples in both pristine and functionalized forms (Fig. 3.3.4B and 3.3.4C). Indeed, in the 
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case of MWCNT-30, we found that OVA adsorption deviates from a linear trend (shown 
by the dashed black line in Fig. 3.3.4B and 3.3.4C) at higher concentrations. On the 
other hand, MWCNT-2 exhibited Langmuir-like isotherm (see inset in Fig. 3.3.4B) in 
both pristine and carboxylated forms. The results indicated that while carboxylated 
MWCNT-2 and MWCNT-30 showed similar adsorption at lower concentrations, both 
trends deviated from linearity albeit in different directions (shown by dashed black line) 
at higher concentrations.  
 






To demonstrate the successful delivery of ovalbumin by MWCNTs into 
macrophages, we employed darkfield microscopy in conjunction with fluorescent Texas 
Red-conjugated ovalbumin to confirm the uptake of MWCNT-TR-OVA complex by 
macrophages (Fig. 3.3.5). After 6 h treatment, macrophages treated with or without 
MWCNTs alone did not show any fluorescence. In comparison, macrophages treated 
with ovalbumin showed fluorescence, and most interestingly, macrophages treated with 
MWCNT-TR-OVA complex displayed strong fluorescence, suggesting that both 







Figure 3.3.5: Delivery of fluorescent Texas Red-conjugated ovalbumin by MWNCT-2 
into bone marrow derived macrophages (BMDM) visualized by darkfield and fluorescent 
microscopy. Macrophages with or without treatment with MWCNTs alone showed no 
fluorescence, but macrophages treated with ovalbumin and MWCNT-TR-OVA complex 
displayed strong fluorescence. (Magnification: 100 X) 
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We found that neither MWCNTs nor MWCNT-OVA complex had an impact on 
cell viability of macrophages up to 5 days using MTS assay (Fig. 3.3.6). We further 
investigated whether MWCNT-OVA complex activated macrophages. Classically 
activated macrophages are characterized by the production of pro-inflammatory 
cytokines, such as TNFα and IL-6, and the expression of MHC class II.[93] Ovalbumin 
alone remarkably induced the production of both TNFα and IL-6 up to 5 days after 
treatment while MWCNT-2 and MWCNT-30 alone had no effect on the production of 
TNFα and IL-6 by macrophages (Ref. [94]). Interestingly, both MWCNT-2-OVA and 
MWCNT-30-OVA complexes induced significantly higher production of both TNFα and 
IL-6 after treatment compared to ovalbumin treatment alone. Importantly, MWCNT-30-
OVA complex induced a greater cytokine production compared to MWCNT-2-OVA 
complex due to higher OVA adsorption. 




























Figure 3.3.6: Effects of MWCNTs or MWCNT-OVA complex on cellular viability of 
BMDM using MTS assay (n=6, mean ± SD). MWCNTs or MWCNT-OVA complex 




As demonstrated above, macrophages were effectively activated by MWCNT-
OVA complexes. Therefore, we further investigated whether these activated 
macrophages, in turn, enhanced CD4+ T cell proliferation using ovalbumin-specific CD4+ 
T cells isolated from OT-II mice. We co-cultured CFSE-labeled OT-II CD4+ T cells with 
macrophages treated with either MWCNTs or MWCNT-OVA complex. As expected, 
ovalbumin alone induced CD4+ T cell proliferation (Fig. 3.3.7A). Interestingly, we found 
that both MWCNT-2-OVA complex and MWCNT-30-OVA complex significantly 
induced the proliferation of CD4+ T cells, but MWCNT alone had no impact on CD4+ T 
cell proliferation (Fig. 3.3.7B and C). We also found that MWCNT-30-OVA complex 
induced greater CD4+ T cell proliferation than MWCNT-2-OVA complex, supported by 
the observation that there were six distinguished generations of CD4+ T cells with 








Figure 3.3.7: MWCNT-OVA complex remarkably induced CD4+ T cell proliferation. 
(A) Proliferation of OT-II CD4+ T cells after co-culture with untreated macrophages 
(black line) and ovalbumin-treated macrophages (red line), (B) proliferation of OT-II 
CD4+ T cells after co-culture with macrophages treated with MWCNT-2 (black line) and 
MWCNT-2-OVA complex (red line), and (C) proliferation of OT-II CD4+ T cells after 
co-culture with macrophages treated with MWCNT-30 (black line) and MWCNT-30-
OVA complex (red line). 
 
3.3.2 Case of single-walled carbon nanotubes 
SWCNTs were generated using a previously described chemical vapor deposition 
(CVD) process.[95] The Raman spectrum of SWCNTs displays a unique radial breathing 
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mode (RBM), which could be used to accurately determine the diameter distribution. As 
shown in Fig. 3.3.8A, the Raman spectra of as-prepared SWCNTs at two excitation 
wavelengths (514.5 and 1064 nm) showed RBMs between 150-180 cm-1 indicating a 
sharp diameter distribution ~1.3-1.6 nm. Ball milling is expected to induce structural 
defects by opening SWCNT end caps in addition to creating atomic vacancies and non-
hexagonal rings in SWCNTs. Indeed, it has been previously shown that intensive ball 
milling for ~50 h completely disrupts SWCNT tubular structure leading to multi-layered 
polyaromatic carbon materials.[96] Accordingly, the ball milling time in this study was 
limited to ~8 h to induce defects while retaining the tubular structure of SWCNTs. The 
Raman spectrum of SWCNTs also was used to quantify the defect density based on the 
ratio of the disorder (or D-band) to graphitic band (or G-band) intensity (Fig. 3.3.8B). 
From Fig. 3.3.8B and C, it is evident that the D-to-G band intensity ratio (ID/IG) increased 
with increasing ball milling time from 0.16 in as-prepared SWCNTs to ~1.5 in 8 h ball 
milled samples. While SWCNTs ball milled for 2 h showed a rapid increase in ID/IG ratio, 
higher ball milling times (4, 6, and 8 h) led to monotonic increase that appeared to be 
saturated ~8 h (Figure 1B: ID / IG Ratio). All ball milled SWCNTs were found to retain 
their tubular structure, as evidenced by the photoluminescence (PL) spectra and TEM 
(Fig. 3.3.8C). The presence of the van Hove singularities (vHS) in SWCNT-electronic 
density of states results in strong PL emission in the infrared region.29 As shown in Fig. 
3.3.8C, a strong PL emission was observed for all SWCNTs ~1560 nm when excited at 
1064 nm. This observation suggests that the one-dimensional tubular structure of 
SWCNTs, necessary for the presence of vHS, was retained in all the ball milled samples. 
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The ball milling process is known to increase the specific surface area of SWCNTs 
through structural defects. To ascertain such changes in surface area, N2 gas adsorption 
experiments were performed. The surface area was found to have a monotonic increase 
with ball milling time up to 6 h (Table 3.3.1). Indeed, the surface area for 6 h ball milled 
SWCNTs was found to increase by almost an order of magnitude. The significant 
decrease in surface area of 8 h-ball milled SWCNTs could be attributed to the formation 






Figure 3.3.8: A. Radial breathing modes from the Raman spectra of As Prepared 
SWCNTs suggest a diameter distribution ~1.4 nm. The spectra were collected using both 
514 and 1064 nm to probe all SWCNT populations. B. Alterations in the defect band (D-
band ~1350 cm-1) in ball milled SWCNTs evidenced by their Raman spectra. All the 
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spectra were normalized to the graphitic or G-band to obtain the ID/IG ratio that is 
indicative of the defect density. Also, plot of ID/IG vs. duration of ball milling (inset) 
shows that there is an initial rapid increase for 2 h ball milling followed by a saturation in 
the defects with increasing ball milling time. The spectra shown in A and B are averaged 
over at least three different sets. C. The photoluminescence spectra of As Prepared and 
ball milled SWCNTs showed an emission peak ~1560 nm. The presence of strong 
emission, unique to the tubular structure of SWCNTs, confirms that the defects were 
introduced while still retaining the tubular morphology. All characterization experiments 
were performed with an n ≥ 3. 
 
SWCNTs Surface Area 
As Prepared 169.668 m
2
/g 
2 h ball milled 301.728 m
2
/g 
4 h ball milled 351.015 m
2
/g 
6 h ball milled 1091.402 m
2
/g 
8 h ball milled 118.165 m
2
/g 






 Serum from mice fed a normal western diet were collected to evaluate the 
biocoronas that formed on SWCNTs. Specifically, following incubation in 10% normal 
serum, individual biocoronal proteins on SWCNTs were identified utilizing label-free 
mass spectrometry. This approach allowed for the identification of specific proteins 
included in the biocoronas of SWCNTs following incubation in normal serum. Following 
identification and assessment of relative quantitative differences between protein 
components of the biocorona we evaluated alterations in the biocorona due to ball milling 
(As Prepared vs Ball milled in normal serum). These comparisons for investigation were 
determined based on the common processing of SWCNTs by ball milling for 
manufacturing and the significant portion of our population that exist with 
hyperlipidemia. Ultimately, these comparisons describe differential biological 





Figure 3.3.9:  Venn diagrams representing the number of proteins found to associate 
with SWCNTs following incubation in 10% normal serum comparing As Prepared 
SWCNTs to SWCNTs that have undergone ball milling. 
 
 Ball milling of SWCNTs is a typical technique utilized in manufacturing that will 
likely alter biomolecule interactions. To evaluate these ball-milled induced changes we 
compared the protein components of the biocorona following incubation in normal 
serum. The identity of the majority of proteins forming the normal biocorona was found 
to be unchanged due to ball milling (Fig. 3.3.9). These commonly identified proteins that 
did not vary due to ball milling included alpha-2-HS-glycoprotein, complement C3, 
fibrinogen, fibronectin, plasminogen, serum albumin and others in the normal biocorona. 
These proteins are similar to our evaluations in Chapter 4 of the proteins of the biocorona 
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that form on multi-walled carbon nanotubes of differing characteristics and Fe3O4 
nanoparticles. These shared proteins are likely associated with the engineered 
nanoparticles due to their relatively high abundance in serum.  Although many proteins 
found to associate with SWCNTs were common between as-prepared SWCNTs and ball 
milled samples, there were a number of unique protein components within each BC.  
Specifically, ball milling, in general, resulted in the association of platelet-like factor 4, 
serum amyloid, carboxylesterase 1C, metalloproteinase inhibitor and others during 
incubation in normal serum.  Ball milling also resulted in the unique association of 
apolipoprotein B-100, platelet-like factor 4, glutathione peroxidase, phospholipid transfer 
protein, alpha-2 antiplasmin and others during incubation in hyperlipidemic serum.  
Interestingly, many proteins unique to the biocorona of ball milled SWCNTs in normal 
serum, are known to function through redox and charge transfer mechanisms. For 
instance, glutathione peroxidase converts H2O2 into water through charge transfer 
reaction while metalloproteinase inhibitors chelate metal ions.[97] Upon ball milling, the 
defects created in SWCNTs are often charged with exoelectrons and the Ni catalyst used 
in SWCNTs synthesis may be exposed, unlike as-prepared SWCNTs.[98] It is plausible 
that the charged defects and exposed metal catalyst increased the affinity for unique 
proteins observed in the biocorona.   
 Further, for samples incubated in normal serum, fewer proteins were found to be 
in common between As-Prepared and ball milled samples as the length of ball milling 
time was extended (Figure 3.3.9). This suggests that a more diverse biocorona may form 
on the surface of SWCNTs as a result of ball milling since fewer proteins are found in 
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common as ball milling time is increased. While the majority of proteins identified were 
found to be in common between As Prepared and ball milled samples it is likely that 
these minor changes in protein identity may influence biological responses as shown in 
the literature with silver nanoparticles.  For example, serum albumin is the primary 
component of the biocorona that forms on silver nanoparticles due to its abundance. 
However, when the inflammatory response by macrophages was evaluated following 
exposure to either silver nanoparticles with a biocorona that only consisted of albumin or 
a complex biocorona differences were evident.[99]  This suggests that minor changes in 
the identity of the biocorona can elicit significant changes in biological responses. 
 
Figure 3.3.10:  Relative abundance of proteins found to associate with 2h ball milled 




Figure 3.3.11: Differences in relative abundance of specific proteins (Transthyretin, 
Clusterin, Complement C1q Subcomponent Subunit B, and Alpha-2-HS-Glycoprotein) 
found to associate with SWCNTs in either normal serum due to ball milling time.  All 
ratios are As Prepared SWCNTs : Ball Milled SWCNTs.  
 
 Many common individual protein components were identified in the biocoronas 
therefore, we next quantitatively evaluated whether ball milling influences their 
abundance in the SWCNT biocorona.  Differences in abundance were evaluated for 
proteins found in common between As Prepared and ball milled SWCNTs following 
incubation in normal serum. Representative data comparing the abundance of commonly 
associated proteins between As Prepared and 2h ball milled SWCNTs following 
incubation in normal serum is shown in Fig. 3.3.10. Ball milling resulted in the decreased 
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abundance of many of these common proteins (higher ratios of As Prepared : 2h ball 
milled). The abundance of many proteins associated with the complement system was 
altered in the biocorona that formed on 2h ball milled SWCNTs compared to As Prepared 
SWCNTs in normal serum suggesting modified interactions with the complement system.  
The complement system is a part of the innate immune system and is involved in the 
removal of foreign objects as well as the inflammatory response.[100]  These alterations 
in the interactions with the complement system due to ball milling may result in modified 
activation of the immune system thereby altering the SWCNT inflammatory response and 
clearance. These findings imply that ball milled SWCNTs are less likely to interfere with 
the adaptive immune response and less likely to trigger an immune response. Although 
many proteins were determined to commonly associate with SWCNTs, ball milling 
influenced their abundance within the biocorona and may ultimately influence cellular 
responses. 
Progressive alterations in individual protein abundance due to ball milling time 
were also analyzed (Fig. 3.3.11). For example, as ball milling time increased, the amount 
of transthyretin was found to decrease on the surface of SWCNTs following incubation in 
normal serum.  Transthyretin is produced by the liver and is a carrier of the thyroid-
derived hormone thyroxine which is responsible for metabolism regulation.[101]  Our 
data suggest that As Prepared SWCNTs may result in increased disruption of the 
endocrine system by binding transthyretin and interfering with the transport of thyroxine 
as compared to Ball Milled SWCNTs. In addition, increased ball milling time led to the 
increased association of clusterin (molecular chaperone protein and lipid transport) 32 and 
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complement C1q subcomponent subunit B (complement cascade) following incubation in 
normal serum. Increased ball milling time corresponded to decreased association of 
alpha-2-HS-glycoprotein abundance following incubation in normal serum. Since alpha-
2-HS-glycoprotein is a large and abundant protein in serum it is likely that as its 
association decreases in the biocorona it is being replaced by smaller and lesser abundant 
proteins.  This enrichment of lesser abundant proteins may alter the cellular interactions 
of the biocorona.  Ultimately, these representative changes in commonly associated 
individual protein abundance demonstrate differences in the biocorona of the SWCNT 
that are dependent on the process of ball milling. These abundance changes and 
alterations in protein identities support differential biological interactions due to ball 
milling and the likelihood of variable cellular and physiological responses. 
Proteins found to associate with As Prepared and Ball Milled SWCNTs incubated 
in either normal serum were evaluated for biological pathways and common protein 
characteristics via gene ontology. This assessment of the data was performed to examine 
specific pathways and protein characteristics which may be potentially altered due to ball 
milling of SWCNTs. As Prepared SWCNTs incubated in normal serum interacted with 
biological pathways including blood coagulation, plasminogen activating cascade, 
Huntington’s disease, integrin signaling pathway and others.  Following ball milling 
SWCNTs incubated in normal serum associated unique proteins which were related to 
blood coagulation, plasminogen activating cascade, inflammation mediated by 
chemokine and cytokine signaling and others. Overall the unique proteins which 
associated with SWCNTs following ball milling only added more proteins to pathways 
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already identified in the As Prepared sample.  This suggests that ball milling increases the 
interactions with pathways SWCNTs already may perturb prior to ball milling. Ball 
milling resulted in the increased association of proteins related to the biological pathways 
of blood coagulation, integrin signaling, plasminogen activating cascade.  The process of 
ball milling also resulted in interactions with proteins related to unique pathways 
compared to the As Prepared sample.  
To examine commonalities between proteins that associate with the surface of 
SWCNTs and the role of ball milling, gene ontology was again utilized to assess protein 
classes.  In normal serum, As Prepared SWCNTs associated protein classes involved in 
enzyme modulation, transfer/carrier, hydrolase, defense/immunity, signaling, receptor 
and others. Following ball milling and incubation in normal serum SWCNTs associated 
an increased number of distinct proteins related to enzyme modulation, transfer/carrier, 
defense/immunity, signaling, and hydrolase. Following ball milling SWCNTs also began 
to interact with proteins classified as structural. Following the process of ball milling, 
additional numbers of unique proteins from classes of enzyme modulation, 
transfer/carrier, defense/immunity, signaling, and cytoskeletal were found to associate. 
These findings demonstrate that following ball milling SWCNTs incubated in normal 
serum interact with the same classes of proteins as the As Prepared SWCNTs. The unique 
proteins found to interact with SWCNTs following ball milling (Fig. 3.3.10) consist of 
additional proteins from these classes. Ball milling, however, appears to increase 






Defects in nanomaterials can play an important role in determining biomolecular 
interactions with serum proteins. SWCNTs with different defect densities were prepared 
by the ball milling process to study the influence of defects on biocorona formation.  Our 
study demonstrates that charged defects induced by the ball milling process result in the 
formation of distinctive biocoronas through the differential association of proteins. 
Specifically, proteins that function through charge transfer and redox mechanisms were 
observed to bind defected SWCNTs.  
Also, we demonstrated that carboxylated MWCNTs displayed no observable 
toxicity to bone marrow-derived macrophages. Rather, an increase in MWCNT defect 
density promoted protein binding leading to successful delivery of ovalbumin into 
macrophages and promoted CD4+ T cell proliferation. Taken together, these data suggest 
that in addition to surface modification such as carboxylation, surface defect density 
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Many of the nanotherapeutics being developed utilize intravenous delivery 
thereby leading to direct vascular exposure of nanoparticles.  However, it is becoming 
recognized that exposure to NPs in animal models induces a variety of vascular effects 
including exacerbation of atherosclerotic plaque formation, vascular inflammation, 
oxidative stress, and modified vascular reactivity [102]–[106].  In general, cardiovascular 
toxicity is of concern regarding the development of NPs and other pharmaceuticals as it is 
often difficult to identify in early toxicity screens and represents a major cause of new 
drugs failing phase II and III clinical studies.  The improvement and development of in 
vitro approach to screen NPs for cardiovascular toxicity prior to in vivo testing is 
therefore needed.  A key to this improvement is the necessity that these in vitro 
approaches accurately depict the in vivo environment. 
 A large and growing portion of the population currently exists with an underlying 
disease state.  These underlying disease states, such as cardiopulmonary diseases, can 
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modify how individuals respond to exposures resulting in exacerbated responses[107]–
[109].  Hyperlipidemia is a significant underlying disease state that is common in a 
significant portion of the U.S. population. Despite many common underlying disease 
states, such as hyperlipidemia within the population, the majority of studies assessing 
NP-induced toxicity are performed in healthy animal models and utilize in vitro models 
representing healthy physiological conditions.  These healthy scenarios often do not 
represent the population in which nano-based therapeutics and diagnostic tools will be 
utilized.  Many diseases such as hyperlipidemia result in altered expression of circulating 
macromolecules such as proteins, peptides, and lipids[110], [111].  Once NPs are 
introduced into a physiological environment they are rapidly coated with macromolecules 
forming a biocorona (BC)[82], [112].  The addition of the BC alters the interactive 
interface of the NP and can thereby result in modified NP clearance, distribution, activity, 
and toxicity[113]–[115], [17]. Variations in the BC resulting from using dissimilar in 
vitro methods and the use of conditions that do not account for diseased physiological 
environments that modify serum content may explain many inconsistencies between in 
vitro toxicity screening and in vivo studies of NP safety[116] (Joris 2013). Therefore, the 
formation of the BC is governed by the physicochemical properties of the NP, as well as, 
the physiological environment [117], [9], [76], [118]–[120]. To date, the examination of 
the toxicological impact of the BC has been performed only assessing the 
physicochemical properties of the NP while ignoring the role of the physiological 
environment and disease related changes in the biological milieu. 
Magnetite, iron oxide (Fe3O4) NPs, are of considerable interest for their 
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biomedical applications, particularly for their use as MRI contrast agents due to their 
superparamagnetic properties[121]. Furthermore, their surfaces are easily modified to 
allow for targeting of particular tissues, specifically for tumor targeting [122]. Due to 
their emerging use in the biomedical field, evaluation of their toxicity is needed 
particularly in individuals with underlying disease states that may influence the formation 
of the BC. Additionally, the BC has been shown to influence the function of Fe3O4 NPs 
by interfering with their contrast abilities when used for MRI [123].  It is unclear how 
differential BC formation on the surface of Fe3O4 NPs due to disease-induced alterations 
in serum content may affect functionality and toxicity. 
In our current study, we evaluated the formation of the BC on Fe3O4 NPs using 
normal/healthy and lipid-rich rat serum. This evaluation assessed changes in NP 
physicochemical properties due to additions of the BCs as well as utilized a proteomic 
approach to identify differences in the protein content of the BCs. Lastly, we assessed the 
toxicological implications of these BCs on Fe3O4 NPs including cellular uptake, 
cytotoxicity, and cell activation.  This toxicological assessment was performed in rat 
aortic endothelial cells (RAEC) and exposures occurred under flow conditions to more 
accurately depict the in vivo environment.  Overall, this study strives to promote our 
understanding of nanotoxicity, as well as, the development of safe nano-therapeutics 
utilizing relevant exposure conditions, which more accurately portrays the in vivo 
environment. 
In addition to the defects in SWCNT structure as shown in Chapter three, 
physiological environment also has a significant impact on the formation of the BC and 
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can alter SWCNT-biomolecular interactions and subsequent cellular responses.  
Individuals that suffer from underlying diseases which modify serum biomolecule 
content will likely form unique BCs compared to healthy individuals. Introduction of NPs 
into these individuals with high cholesterol may result in altered BC formation that 
impacts NP-cellular interactions and responses. This BC that formed in high cholesterol 
serum exacerbated the inflammatory response of endothelial cells following exposure 
compared to normal serum BCs. This finding demonstrates how disease-induced 
alterations in the physiological environment can impact NP biological response by 
altering the BC.         
 
4.2 Materials and methods 
 
4.2.1 Isolation of Normal and Hyperlipidemic Rat Serum   
Serum samples were kindly provided by Dr. Urmila Kodavanti at the US 
Environmental Protection Agency.  Briefly, healthy male Sprague Dawley rats (Charles 
River Laboratories Inc, Raleigh NC) received water ad libitum and were fed either a 
normal diet of standard (5001) Purina rat chow (Brentwood, MO) or a diet high in 
fructose (60%) (TD89247, Harlan Laboratories, Madison, WI).  All rats were maintained 
in an isolated animal room in an Association for Assessment and Accreditation of 
Laboratory Care (AALAC) approved animal facility 21 ± 1° C, 50 ± 5% relative 
humidity, and 12 h light/dark cycle. Following 2 weeks on the diets animals were 
necropsied and blood was collected without anticoagulant present via abdominal aortic 
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puncture.  Following processing of serum, samples were pooled and aliquoted to be 
stored at -80°C.  Serum from rats fed a normal diet (normal serum) demonstrated a 
cholesterol content of 122.27 mg/dl whereas serum from rats fed a high fructose diet 
(lipid serum) demonstrated a cholesterol content of 253.11 mg/dl.  The U.S. EPA 
NHEERL Institutional Animal Care and Use Committee (IACUC) approved the protocol.  
The animals were treated humanely and with regard for alleviation of suffering. 
 
4.2.2 Formation and characterization of Fe3O4 Nanoparticle-Biocorona 
Spherical 20 nm Fe3O4 NPs suspended in PVP at a concentration of 20 mg/ml 
were purchased from Nanocomposix (San Diego, CA).  BCs were formed on Fe3O4 NPs 
as described in our recent publications [76], [124], [99], [125].  Fe3O4 NPs were diluted 
in water to a concentration of 1 mg/ml incubated for 8 h at 10° C in distilled (DI) water 
(control), 10% normal serum, or 10% lipid-rich serum.  Specifically, 250 ul of Fe3O4 NP 
(1 mg/ml), 650 μl of water, and 100 μl of serum were combined in a 1.5 ml tube. 
Following incubation Fe3O4 NPs were then pelleted via centrifugation 14,000 rpm 
(20,817 x g) 10 min and washed with PBS.  Following centrifugation, the supernatant 
was removed and Fe3O4 NP was resuspended with 250 μl of water to its initial 
concentration of 1 mg/ml.  The BC formed following incubation of Fe3O4 NPs in normal 
serum is referred to as Fe3O4 NP – Normal BC whereas the BC form following 
incubation in lipid-rich serum is referred to as Fe3O4 NP – Lipid BC. 
For characterization, we measured the hydrodynamic size and zeta potentials 
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(ZetaSizer Nano, Malvern) of uncoated Fe3O4 NPs, and Fe3O4 NPs with BCs in DI water 
with Fe3O4 NPs at a concentration of 50 μg/ml (n=3/particle).  Cholesterol content of the 
BCs formed on the surface of Fe3O4 NPs was evaluated via a commercially available 
colorimetric total cholesterol assay kit (Cell Biolabs, San Diego, CA) following 
manufacturer’s instructions.  Briefly, 50 μl of Fe3O4 NPs without or with BCs were 
loaded into a 96 well plate in duplicate and then were treated with a cholesterol reaction 
reagent that includes cholesterol esterase, cholesterol oxidase, and a colorimetric probe.  
The cholesterol esterase causes the hydrolysis of cholesterol esters from the cholesterol 
bound to the Fe3O4 NPs allowing for their determination.     
Transmission electron microscopy images were obtained using a Hitachi H7600 
microscope. For TEM studies, Fe3O4 NP – Normal BC and Fe3O4 NP – Lipid BC 
samples were stained by incubating them in 0.1% OsO4 solution for 30 min. The samples 
were washed with double distilled water to remove unbound OsO4 after which the 
samples were drop casted on a 400 mesh Cu grid and dried overnight. Z-contrast images 
were also acquired using Hitachi HD2000 microscope without staining the samples. The 
high Z-contrast between Fe3O4 NPs and BC allowed us to distinguish the two phases (i.e., 
NPs and BC).   
Utilizing a proteomics approach, individual protein components of the BCs were 
identified similar to our previous studies evaluating the BC.  Briefly, following the 
addition of the BCs, Fe3O4 NPs were washed and pelleted three times with PBS (10 min 
14,000 rpm / 20,817 x g).  Proteins were then solubilized using 8 M urea and 10 mM 
dithiothreitol (DTT) for 45 min at 60 °C.  Fe3O4 NPs were then pelleted via 
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centrifugation at 15,000 x g for 10 min and the supernatant containing solubilized 
proteins was collected.  Protein samples were then treated with 30 mM iodoacetamide for 
30 min in the dark at room temp followed by the addition of 10 mM DTT in 50 mM 
ammonium bicarbonate (ABC) for 30 min at room temperature. Finally, 50 mM ABC 
was used to dilute remaining urea to less than 1 M.  Samples were then proteolyzed using 
porcine trypsin (0.1 μg/ml) overnight at 37 °C, heated to 90 °C to deactivate trypsin, and 
concentrated to dryness.  Samples were then resuspended in 0.1% trifluoroacetic acid in 
water, purified via Ziptip Pipette Tips (Millipore, Billerica, MA), and concentrated to 
dryness.  Samples were then resuspended in 0.1 % Formic Acid in DDI water and 
injected into a Bruker Impact HD Q-TOF mass spectrometer (Bruker Daltonic, Billerica, 
MA).  The acquired data were searched using a MASCOT (ver. 2.4.1) search engine with 
a peptide cutoff of 10 ppm and a minimum peptide score of 20 and a protein score of 40.  
The false discovery rate for samples was < 1% and the significance threshold was p < 
0.05. To determine differences in common protein components of the BCs, ratios of 
individual proteins were assessed utilizing Proteinscape and Profileanalysis software 
packages (Bruker Daltonic, Billerica, MA).  Four samples of each BC were analyzed 
individually and injected 4 separate times.  Peptides to be considered for evaluation had 
to be found within 5 of 8 samples with a minimum of 2 per BC type.  Only peptides 
determined to be statistically significant were utilized to calculate ratios and more than 
one peptide had to be identified for a protein for that individual protein to be quantified. 
4.2.3 Cellular uptake and cytotoxicity 
Rat aortic endothelial cells (RAEC) were cultured in rat endothelial cell growth 
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media (Cell Applications Inc., San Diego, CA).  Cell lines were maintained in flasks 
under standard conditions at 37°C and 5% CO2.  For the assessment of the BC and its 
role in cellular responses, all experiments were performed utilizing serum-free media as 
done in our previous experiments [99], [125].  The removal of serum from media allows 
for the evaluation of the intentionally formed BC without the addition of a secondary BC 
within the cell culture system.  The use of serum-free media limits the study of the BCs 
and the cellular responses to acute time points. 
  To assess Fe3O4 NP Cytotoxicity  RAEC cells were grown to 90% confluency in 
96 well plates (Costar) and were exposed to increasing concentrations of Fe3O4 NPs (0, 
2.5, 5, 10, 20, 40, 80 μg/ml) with or without BCs for 2 h and 6 h in serum-free media in a 
static system.  Cells were exposed in this static system due to the high number of 
concentrations evaluated and to screen for overt cytotoxicity.  Due to the use of serum-
free media, later time points were not evaluated.  The concentrations of Fe3O4 NPs 
utilized were selected based on possible human exposures as well as previous in vitro 
examination of Fe3O4 NPs and other NPs.  Briefly, concentrations of Fe3O4 NPs were 
determined based on levels used for human MRI analysis utilizing Fe3O4 NPs as a 
contrast agent, which typically range from 5-10 μg/ml blood volume, considering a male 
of 90 kg [126], [127]. Changes in cell viability were assessed via the 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxmethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium 
(MTS) assay (Promega, Madison, WI) via manufacturer’s instructions using a 
spectrophotometer (BioTek Synergy HT, BioTek, Winooski, VT).  No overt cytotoxicity 
was identified therefore a concentration of 20 μg/ml was utilized for all subsequent 
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experimentation of RAEC uptake and activation. This concentration of 20 μg/ml was also 
selected due to it being within the range of a human-relevant concentration. 
In order to more accurately depict the in vivo environment, RAEC uptake of 
Fe3O4 NPs was assessed utilizing a Quasi Vivo system (Kirkstall, Rotherham, UK) that 
pumps media over the surface of the cells.  RAECs were grown on coverslips and placed 
into an individual chamber.  Serum-free media (control), serum-free media containing 
Fe3O4 NPs – Normal BC, or serum-free media contain Fe3O4 NPs – Lipid BC at a 
concentration of 20 μg/ml was loaded into the reservoir.  A flow rate of 1 ml/min of fluid 
was utilized during the 2 h exposure.  This NP concentration and time point were select 
for the evaluation of cellular uptake based on previous research examining the uptake of 
other NPs by RAECs and possible human blood concentrations of Fe3O4 NPs when 
utilized as an MRI contrast agent.  The flow rate of 1 ml/min was estimated to result in a 
shear stress of 100 x 10-3 Pa.  The Quasi Vivo system as manufactured can produce a 
shear stress of 2 x 10-5 Pa at a flow rate of 1 ml/min[128], however by inserting silicone 
glue into the base of the chamber thereby raising the cells nearer to the inlet of media a 
higher shear stress can be achieved. For comparison, a shear stress of 1.5-2.0 Pa occurs in 
human arteries while the higher diameter post-capillary venules have a shear stress at 300 
x 10-3 Pa [129], [130].  A shear stress of 100 x 10-3 Pa is below the necessary 200 x 10-3 – 
5 Pa need to induce cell alignment and tight junctions in vitro [131].  Therefore this shear 
stress utilized in this study will not induce biological responses by itself. Following 
exposure, coverslips were removed from the chamber and placed into a 24 well plate.  
Cells were then detached with 250 μl of trypsin and neutralized with an equal volume of 
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RAEC media.  Cells were then washed 3 times with PBS and differences in uptake were 
determined by ICP-MS analysis of Fe content.  All samples were dissolved in 6 ml of 2% 
HNO3.  The Fe concentration was determined with ICP-MS (X series II, Thermo 
Scientific) using an internal standard containing Li, Y and In with a detection limit of 3 
ppb.  Qualitative assessment of Fe3O4 NP uptake was performed by darkfield microscopy 
(Cytoviva, Auburn, AL).  RAECs underwent the same exposure protocol, were fixed with 
2% paraformaldehyde and had their nucleuses stained with DAPI.  Focusing on the 
nucleus allowed for the assessment of internalized Fe3O4 NPs. 
RAEC activation by Fe3O4 NPs without or with BCs was assessed utilizing a 
Quasi Vivo system (Kirkstall, Rotherham, UK) at a flow rate of 1 ml/min of fluid.  
RAECs were grown on coverslips and placed into an individual chamber.  Serum-free 
media (control), serum-free media containing Fe3O4 NPs – Normal BC, or serum-free 
media contain Fe3O4 NPs – Lipid BC at a concentration of 20 μg/ml was loaded into the 
reservoir and cells were exposed for 1 h.  Total RNA was isolated from cells using 
Direct-zol RNA MiniPrep (Zymo Research Corp., Irvine, CA) via manufacturer’s 
instructions and quantified via nanodrop (Nanodrop 2000c Spectrophotometer, Thermo 
Scientific).  Total RNA was reverse transcribed to cDNA using an iScript cDNA 
Synthesis Kit (Bio-Rad Laboratories, Hercules, CA).  A rat endothelial cell biology PCR 
array was utilized to identify markers of endothelial activation following exposure to 
Fe3O4 NPs without or with BCs (RT2 Profiler PCR Array Systems, Cat# PARN-015Z, 
SABiosciences; Frederick MD).  This PCR array identified 84 genes related to 
angiogenesis, vasoconstriction/dilation, inflammatory response, apoptosis, cell adhesion, 
 
 65 
coagulation and platelet activation.  Plates were prepared according to manufacturer’s 
instructions and using a StepOnePlue Real-Time PCR System (ABI, Foster City, CA).  
Data analysis on SaBiosciences web-based PCR array expression analysis suite utilized 
the ΔΔCt method with normalization to β-actin (housekeeping gene) and considering 
serum-free media exposed cells as controls.   
All data are presented as mean ± SEM consist of 3-6 experiments. Data were 
analyzed by one-way ANOVA, with differences between groups assessed by Tukey’s 
post hoc tests. All graphs and analysis were performed using GraphPad Prism 6 software 
(GraphPad, San Diego, CA, USA).  Statistical significance was determined when p was 
found to be less than or equal to 0.05 between groups. 
 
4.2.4 Formation and evaluation of the SWCNT-Biocoronas   
BCs were formed on SWCNTs (n=6/group) using a modified Tenzer’s method, as 
described in our recent publications.[76], [118], [132]  Individual SWCNTs were 
suspended water at a concentration of 1mg/ml and incubated in either 10% normal or 
10% hyperlipidemic serum to be mixed constantly for 8 h at 4C.  Specifically, SWCNTs 
following suspension were sonicated for 5 min in an inverted cup-horn sonicator at an 
amplitude of 75.  250 ul of SWCNTs (1mg/ml), 650 ul of water, and 100 ul of serum 
were combined in a 1.5 ml tube.  Following the 8 h incubation SWCNTs were pelleted 
via centrifugation 14,000 rpm (20,817 x g) 10 min and washed with PBS. This washing 
process was repeated three times. Following the final centrifugation, the supernatant was 
removed and SWCNTs were resuspended with 250 ul of water to their initial 
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concentration of 1 mg/ml.  The BC formed following incubation of SWCNTs in normal 
serum is referred to as SWCNT-Normal BC whereas the BC formed the following 
incubation in hyperlipidemic serum is referred to as SWCNT-Lipid BC.  
We used proteomics approach to individual protein components of the BCs 
similar to our previous studies evaluating the BC.[28]  Briefly, following the addition of 
the BCs, SWCNTs were washed and pelleted three times with PBS (10 min 14,000 rpm / 
20,817 x g).  Proteins were then solubilized using 8 M urea and 10 mM dithiothreitol 
(DTT) for 45 min at 60 °C.  SWCNTs were then pelleted via centrifugation at 15,000 x g 
for 10 min and the supernatant containing solubilized proteins was collected.  Protein 
samples were then treated with 30 mM iodoacetamide for 30 min in the dark at room 
temp followed by the addition of 10 mM DTT in 50 mM ammonium bicarbonate (ABC) 
for 30 min at room temperature. Finally, 50 mM ABC was used to dilute remaining urea 
to less than 1 M.  Samples were then proteolyzed using porcine trypsin (0.2 ng/μl) 
overnight at 37 °C, heated to 90 °C to deactivate trypsin, and concentrated to dryness.  
Samples were then resuspended in 0.1% trifluoroacetic acid in water, purified via Ziptip 
Pipette Tips (Millipore, Billerica, MA), and concentrated to dryness.  Samples were then 
resuspended in 0.1 % Formic Acid in HPLC-grade water and injected onto a nHPLC 
utilizing a flow rate of 800 nL/min with a gradient of 5-50% 0.1% formic acid in 
acetonitrile (ACN) over 30 min on C18 trapping (20x0.1 mm2) and analytical columns 
(150x0.1 mm2).  The nLC was coupled to a nano-ESI source and Impact HD Q-TOF 
mass spectrometer (Bruker Daltonics, Inc., Billerica, MA).  The acquired data were 
searched using a MASCOT (ver. 2.4.1) search engine with a peptide cutoff of 10 ppm 
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and a minimum peptide score of 20 and a protein score of 40.  The false discovery rate 
for samples was < 1% and the significance threshold was p < 0.05. These identified 
proteins were then assessed for biological pathways SWCNTs may interfere with and 
common protein characteristics by via the Gene Ontology Consortium database 
(geneontology.org,) and using only mapped identifiers. To determine differences in 
common protein components of the BCs, ratios of individual proteins were assessed 
utilizing ProteinScape and ProfileAnalysis software packages (Bruker Daltonic, Billerica, 
MA).  Four samples of each BC were analyzed individually and injected 4 separate times.  
Peptides to be considered for evaluation had to be found within 5 of 8 samples with a 
minimum of 2 per BC type.  Only peptides determined to be statistically significant were 
utilized to calculate ratios and more than one peptide had to be identified for a protein for 
that individual protein to be quantified.  Data generated allowed for comparisons of the 
BCs between SWCNTs that had undergone ball milling resulting in altered defect loads 
and comparisons between the BCs that formed under the differing physiological 










4.3 Results and discussion 
4.3.1 Case of Fe3O4   
 
Nanoparticle Hydrodynamic Size 
(nm) 




Fe3O4 103.0 ± 2.3 -34.1 ± 0.6 ------------ 
Fe3O4 – Normal BC 117.3  ± 5.5 -24.1 ± 0.4 * 7.2  ± 0.3 
Fe3O4 – Lipid BC 107.4  ± 5.5 -23.0 ± 1.4 * 62.2  ± 13.1
# 
Table 4.3.1: Fe3O4 NP-Biocorona Characterization (n=3). * denotes statistical difference 
from Fe3O4 without BC (p ≤ 0.05). 
# denotes statistical difference from Fe3O4 – Normal 
BC (p ≤ 0.05). 
 
Figure 4.3.1: Venn diagram representing the distribution of protein components found to 
associate with 20 nm Fe3O4 NPs following incubation in 10% normal (blue) or 




Following incubation of Fe3O4 NPs in 10% normal or lipid-rich serum and 
formation of the biocoronas (BC), hydrodynamic size and zeta potential were assessed 
(Table 4.3.1).  Formation of either BC slightly increased the hydrodynamic size of the 
Fe3O4 NPs (Table 4.3.1).  However, the formation of both the normal BC and lipid BC 
on Fe3O4 NP resulted in a significant decrease in zeta potential (Table 4.3.1).   
Variations in the cholesterol content and protein components of the BCs formed 
on Fe3O4 NPs in the differing physiological environments were evaluated. Assessment of 
the cholesterol content of each BC demonstrated cholesterol as a component of both BC.  
As expected, the lipid BC had a greater amount of cholesterol associated with it 
compared to the normal BC (Table 4.3.1).  Label-free proteomics was utilized to evaluate 
differences in protein components of the BCs.  The BCs on Fe3O4 NPs incubated in either 
normal or lipid-rich serum were found to consist of 103 or 121 individual proteins 
respectively (Fig. 4.3.1).  In common between the two BCs were 92 proteins including 
complement C3, prothrombin, serum albumin, serotransferrin, alpha-2-HS glycoprotein, 
apolipoprotein A-II, apolipoprotein E, and apolipoprotein C-I (Fig. 4.3.1). Fe3O4 NP with 
a normal serum BC was determined to bind 11 unique proteins when compared to Fe3O4 
NP with a lipid-rich BC.  Fe3O4 NP with a lipid-rich BC was found to bind 29 unique 
proteins when compared to Fe3O4 NP with a normal BC. A complete list of all proteins 
found to associate with Fe3O4 NP following incubation in the different physiological 




Figure 4.3.2. False-colored transmission electron micrographs for (a) Fe3O4 NPs, (b) 
Fe3O4-Normal BC, and (c) Fe3O4-Lipid BC. Biocorona is shown in blue (b) and green 
colors (c). The Fe3O4 NPs were observed to be embedded in BC. The black arrows in (c) 
show liposome structures formed in Fe3O4-Lipid BC.  
 
As shown in Fig. 4.3.2, bare Fe3O4 NPs were found to have a mean size of ~30 
nm. This is significantly smaller than the hydrodynamic size (>100 nm) suggesting that 
there may be some agglomeration of Fe3O4 NPs in solution. Additionally, TEM images 
showed that the Fe3O4 NPs are not completely spherical. We found that both Fe3O4- 
Normal BC and Fe3O4- Lipid BC contained Fe3O4 NPs embedded BC (Fig. 4.3.2 B and 
C). Interestingly, we also found the presence some liposomes in Fe3O4-Lipid BC, which 
were confirmed by OsO4 staining and Z-contrast studies.  
 To determine possible differences in cytotoxicity due to the addition of the BCs, 
rat aortic endothelial cells (RAECs) were exposed to Fe3O4 NPs without or with BCs at 
concentrations of 2.5, 5, 10, 20, 40, or 80 μg/ml for 2 h or 6 h and examined for 
differences in viability.  This initial assessment of cytotoxicity was performed in a static 
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cell culture system due to the number of concentrations examined. Due to the removal of 
serum from the cell culture media, only acute time points were evaluated.  None of the 
concentrations utilized were found to induce significant cytotoxicity.  Furthermore, the 
addition of the BCs was not found to alter cytotoxicity.  Based on these data, previous 
work evaluating NP toxicity in RAEC, and relevant human concentrations a 
concentration of 20 μg/ml was utilized for all experimentation investigating disease-
induced BC toxicity [126], [127] 
 
Figure 4.3.3:  Measurement of 20 nm Fe3O4 NP uptake by ICP-MS and darkfield 
microscopy.  Rat aortic endothelial cells (RAEC) were exposed to serum-free media 
(control), Fe3O4 NPs without a biocorona (BC), or Fe3O4 NPs with either a normal serum 
or lipid serum BC.  Cells were exposed to a concentration of 20 μg/ml for 2 h under flow 
conditions of 1 ml/min.  A) Following exposure, cells were assessed by ICP-MS for 
Fe3O4 NP uptake. Values are expressed as mean ± SEM (n=3/group). * Indicates 
significant difference from controls (p < 0.05).  B) Alterations in RAEC uptake of Fe3O4 
NPs due to the addition of BCs was qualitatively evaluated via darkfield microscopy. 
Fe3O4 NPs without a BC are identified with red arrows, Fe3O4 NP-normal BC with blue 
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arrows, and Fe3O4 NP-lipid BC with green arrows. 
 BC-induced alterations in RAEC uptake were evaluated by ICP-MS and darkfield 
microscopy (Figure 4).  RAECs were exposed to 20 μg/ml of Fe3O4 NPs without or with 
BCs for 2 h under a flow rate of 1 ml/min.  RAECs were found to readily internalize 
Fe3O4 NPs without a BC, however, addition of both BCs resulted in reduced uptake as 
evaluated by ICP-MS (Fig. 4.3.3A).  These results were qualitatively confirmed via 
darkfield microscopy (Fig. 4.3.3B).  Fe3O4 NPs without a BC were internalized (red 
arrows) to a greater degree than Fe3O4 NPs with a normal BC (blue arrows) or Fe3O4 NPs 
with a lipid BC (green arrows).  
To determine differences in Fe3O4 NP-induced RAEC activation due to the 
addition of the BCs, mRNA gene expression was examined.  RAECs were exposed for 1 
h to 20 μg/ml of Fe3O4 NPs without or with BCs under a flow rate of 1 ml/min.  A PCR 
array specific for rat endothelial cell biology was utilized which evaluated mRNA 
expression changes in 85 genes related to a variety of processes.  These processes 
included angiogenesis, vasoconstriction/dilation, inflammatory response, apoptosis, cell 
adhesion, coagulation and platelet activation.  In summary, RAECs exposed to Fe3O4 
NPs without a BC demonstrated a significant (p ≤ 0.05) upregulation of 4 genes and 
downregulation of 10, while cells exposed to Fe3O4 NPs with a normal BC had 7 genes 
upregulated and 18 down-regulated and those exposed to Fe3O4 NPs with a lipid BC had 
10 genes upregulated and 8 down-regulated.  Exposure to all Fe3O4 NPs (without and 
with BCs) significantly altered the expression of a subset of genes in common including 
the upregulation of Cx3cl1, Cxcl1, Selp, and VCAM1 and the downregulation of Ednra, 
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Hif1a, and Sod1. Inflammatory genes such as IL-6, Cxcl1, Cxcl2, and TNF were induced 
to a greater degree upon RAEC exposure to Fe3O4 NPs with BCs compared to the 
absence of a BC.  The induction of these inflammatory genes was greatest in RAECs 
exposed to Fe3O4 NPs with a lipid BC.  Verification of VCAM-1 mRNA expression seen 
in the PCR array through real-time PCR demonstrated similar gene induction.  Additional 
controls were added to this experiment to ensure that changes seen in mRNA expression 
were not related to carry over of free serum proteins (proteins not associated with Fe3O4 
NP BCs).  These control groups demonstrated no changes in VCAM-1 mRNA 
expression. To further assess activation of RAEC by Fe3O4 NPs without or with BCs, cell 
surface expression of VCAM-1 was evaluated by immunofluorescence (Fig. 4.3.4).  Cells 
again were exposed under flow conditions of 1 ml/min to Fe3O4 NPs without or with BCs 
(20 μg/ml) for 1 h and stained for VCAM-1 expression.  Fe3O4 NPs without a BC and 
Fe3O4 NPs with a normal BC did not demonstrate differences in VCAM-1 expression 
compared to controls (Fig.4.3.4).  Exposure to Fe3O4 NPs with a lipid BC, however, did 
demonstrate increased cell surface expression of VCAM-1.  This alteration in surface 





Figure 4.3.4:  Assessment of Fe3O4 NP-BC alterations in cell surface expression of 
VCAM-1 by immunofluorescent staining.  Rat aortic endothelial cells (RAEC) were 
exposed to serum-free media (control), Fe3O4 NPs without a BC or Fe3O4 NPs with either 
a normal serum or lipid serum BC.  Cells were exposed to a concentration of 20 μg/ml for 
1 h under flow conditions of 1 ml/min.  Cells were then immunofluorescently stained 
with DAPI to identify the nucleus (Blue) and with a VCAM-1 antibody to identify 





4.3.2 Case of SWCNTs 
A substantial portion of our population exists with an underlying health condition. 
These underlying conditions often modify the biomolecular content of the individual’s 
serum. Since the formation of the biocorona is dependent on both the physicochemical 
properties of the engineered nanomaterial as well as the physiological environment it 
likely that underlying disease states will result in unique biocorona formation.21 One 
highly prevalent and growing disease state is hyperlipidemia or high cholesterol. Previous 
evaluation has demonstrated that incubation of iron oxide nanoparticles in hyperlipidemic 
serum results in the formation of unique biocoronas compared to incubation in normal 
serum.21 Further, the addition of the hyperlipidemic biocorona was determined to induce 
greater inflammatory responses in endothelial cells suggesting increased toxicity of 
nanoparticles in individuals with hyperlipidemia.  In our current study, we evaluated the 
biocorona that forms on SWCNTs that have been either untreated or ball milled in both 
normal and hyperlipidemic serum. In order to understand nanoparticle-biomolecular 









Figure 4.3.5:  Venn diagrams representing the number of proteins found to associate with 
SWCNTs due to incubation in either normal or hyperlipidemic serum. 
 
 A proteomic comparison of the protein components of the biocorona that forms 
on SWCNTs following incubation in either normal or hyperlipidemic serum 
demonstrated that the majority of proteins were in common (Fig. 4.3.5).  These common 
proteins included apolipoprotein AI, C reactive protein, fibronectin, kininogen-1, 
plasminogen, and others.  Unique to the normal serum biocorona were proteins alpha-1 
antitrypsin 1-4, hemoglobin subunit A, and others.  Unique to the hyperlipidemic 
biocorona were hepcidin, extracellular matrix protein 1, antithrombin-III, and others. 
Interestingly, as ball milling time was increased, fewer proteins were shared between the 
normal and hyperlipidemic serum biocoronas. This corresponded with a trend of more 
unique proteins in the normal serum biocorona compared to the hyperlipidemic serum 
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biocorona as ball milling time increased (Fig. 4.3.5).  Further, the hyperlipidemic serum 
biocorona demonstrated less unique proteins compared to the normal serum biocorona as 
ball milling time increased.  It is likely that due to the amount of cholesterol present in 
the hyperlipidemic serum that cholesterol outcompeted proteins for binding sites on the 
SWCNTs. This competition may explain the decreases in common proteins between the 
normal and hyperlipidemic biocoronas as increased ball milling time enhanced the 
surface area of SWCNTs resulting in more cholesterol association. To date, few studies 
have evaluated the lipid content of the biocorona that forms on engineered nanomaterials. 
Future research is needed regarding the association of lipids on engineered nanomaterials 
in physiological environments.[133]  It is likely that they not only modify the association 




Figure 4.3.6: Differences in relative abundance of specific proteins (Transthyretin, 
Clusterin, Complement C1q Subcomponent Subunit B, and Alpha-2-HS-Glycoprotein) 
found to associate with SWCNTs in hyperlipidemic serum due to ball milling time. For 
normal serum refer Fig. 3.3.11.  All ratios are As Prepared SWCNTs : Ball Milled 
SWCNTs. 
 
 Although a majority of proteins were shared between the normal and 
hyperlipidemic biocoronas on SWCNTs differences were determined regarding their 
abundance (Fig. 4.3.6). Many proteins such as immunoglobulin kappa V-III, 
apolipoproteins E, C-I, A-II, and A-I, and complement C1q subcomponent subunit B, 
complement C1s-A subcomponent, complement C3 and complement C1r-A 
subcomponent were found to be enriched within the hyperlipidemic biocorona on As 
Prepared SWCNTs. As Prepared SWCNTs in hyperlipidemic serum associated greater 
amounts of apolipoproteins and complement factors likely due to their increased 
abundance in hyperlipidemic serum. Many of the shared proteins found to be decreased 
in the hyperlipidemic compared to the normal biocorona appear to be high abundant 
serum proteins.  This suggests that the increased lipid content maybe competing with 
them for binding sites on the SWCNTs. Further, this data overall demonstrates that the 
biocorona is not only different due to structural modification induced by ball milling but 
also due to the physiological environment. Although they share numerous proteins the 
abundance of these proteins are not uniform.  These variations in abundance further 
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demonstrate altered biomolecular interactions, distinct biocorona formation, and the 
possibility for modified cellular responses.   
 Again, gene ontology was used to evaluate proteins related to specific biological 
pathways and classes of proteins that associated with SWCNTs. For this comparison of 
biological pathways and protein classes, proteins that were found to bind in common 
between normal and hyperlipidemic serums regardless of ball milling were utilized. 
Further only proteins that were unique and never shared between samples were used to 
explain pathways and classes that were unique to serum environment. Assessment of 
commonly associated proteins demonstrated that proteins associated with the biological 
pathways of blood coagulation, integrin signaling, inflammation-mediated by chemokine 
and cytokine signaling, vitamin D metabolism, plasminogen activating cascade and 
others.  Assessment of the unique protein components of the biocoronas primarily added 
proteins to the identified common pathways. The hyperlipidemic biocorona on SWCNTs 
however uniquely associated glyceraldehyde-3-phosphate dehydrogenase which is 
involved in the biological pathway of glycolysis. Although most of the proteins that 
associated with SWCNTs in normal and hyperlipidemic serums were associated with the 
same biological pathways it is interesting that there were unique proteins that bound.  
Therefore, classes of the proteins that associated with SWCNTs were evaluated. Proteins 
that bound in common were found to have been from classes of proteins involved in 
enzyme modulation, transfer/carrier, defense/immunity, signaling, transporter, receptor 
and others. Uniquely associated proteins primarily were from similar classes to the ones 
that were shared of proteins that were shared.  The hyperlipidemic biocorona, however, 
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was found to associate with single proteins from the classes of transcription factor and 
nucleic acid binding (transcription factor HIVEP2), and isomerase (major urinary 
protein-1). Again, this assessment demonstrated that although proteins that bound to the 




In summary, our study demonstrates the impact of underlying disease states on 
the formation of the BC on Fe3O4 NPs and its implications for the safe development of 
NPs for biomedical applications.  Although numerous studies have demonstrated that the 
physicochemical properties of NPs result in differential BC formation, few have 
examined the role of the physiological environment in terms of variations due to 
underlying disease states.  The addition of the lipid BC was determined to influence 
cellular uptake and activation, thereby having consequences for the safe utilization of 
NPs.  In the current study we investigated a common human disease state, 
hyperlipidemia, however, numerous other conditions are known to alter physiological 
environments, which may influence the formation of the NP-BC and toxicity thereby 
requiring additional investigation.  There are also many other biological fluids other than 
serum that NPs may come into contact with due to their routes of exposure such as 
bronchoalveolar fluid, gastrointestinal fluid, and others.  In order for the safe and 
effective use of NPs for biomedical applications, it is necessary to evaluate the formation 
of the BC in different environments and assess its impact on NP function and toxicity. 
 
 81 
A common disease-induced alteration in the serum environment can also result in 
modified biocorona formation. Further, these disease-related changes in the physiological 
environment demonstrate differences due to SWCNTs ball milling when compared to 
normal conditions. Toxicological experimentation of exposures to SWCNTs often 
focuses on end product exposure and healthy/normal physiological conditions. However, 
often nanomaterials are modified through processes such as ball milling which may 
influence nanomaterial-biomolecule interactions. In order to protect the population from 
unintended adverse responses, it is necessary to understand how these modifications in 
the nanomaterial’s surface and the biological environment can alter nanomaterial-
biomolecule interactions which may govern biological responses such as toxicity, 
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There is an immediate need to focus our attention on emerging two-dimensional 
(2D) layered materials such as graphene, graphene oxide (GO), and BN. Many medical 
applications are envisaged for 2D materials in multiple areas including cancer drug 
delivery, clot-resistant coatings for biomedical implants, and biomedical imaging[134]–
[139]. In the physiological environment, the high surface area of 2D materials, compared 
to 0D and 1D materials[140], opens new possibilities for relatively stronger non-covalent 
biological interactions through efficient  stacking and hydrogen bonding with 
biomolecules present in the biocorona. A critical first step in understanding the formation 
and subsequent influence of biocorona is to study how 2D materials (essentially 
equivalent to surfaces) interact with amino acids. The aromatic rings in certain amino 
acids (e.g., tryptophan, tyrosine, and phenylalanine) could be expected to interact 
strongly with 2D materials, and thereby adversely influence the transport and uptake of 
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essential amino acids critical for protein synthesis. It is known that deficiencies in even a 
single essential amino acid (e.g., tryptophan) could alter immunity and increase disease 
susceptibility.[141] Furthermore, it has been suggested that the adsorption characteristics 
of a diverse set of small molecules such as amino acids could be used to develop 
quantitative-structure activity relationships or QSARs for predicting biocoronal 
fingerprint of ENMs[142]. Therefore, it is important to understand the interactions 
between 2D ENMs and amino acids in order to guide the emerging medical applications 
and aid in the development of new toxicity and QSAR models. To this end, we used 
micro-Raman and photoluminescence spectroscopy combined with electrochemical 
characterization to study the electronic interactions between three aromatic amino acids 
(tryptophan, tyrosine, and phenylalanine) and three different types of 2D materials 
(graphene, GO, and BN). As demonstrated in this study, the interactions between 
biomolecules and 2D materials significantly perturb the ENM electronic structure, which 
could be elucidated through changes in the Raman spectra of 2D materials and quantified 
using cyclic voltammetry. The rationale for choosing this particular set of 2D materials 
(viz., graphene, GO, and BN) is multi-fold: i) the widely used graphene and GO exhibit 
strong non-covalent interactions (stacking and hydrogen bonding) with aromatic 
molecules due to delocalized electrons or the presence of functional groups, ii) although 
graphene and BN are structural analogues, they exhibit differences in  -electron cloud 
distribution. The  -electron cloud is uniformly delocalized in graphene while it is 
centered near N atoms in BN. Such differences facilitate the investigation of different 
orientations in stacking, and iii) while graphene and BN are hydrophobic, GO is 
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hydrophilic and has been proposed to exhibit possible hydrogen bonding with 
biomolecules leading to interactions distinct from graphene and BN[143].  Our results 
show that tyrosine and tryptophan strongly interact with 2D materials, unlike 
phenylalanine. More importantly, we found evidence for charge transfer between 
aromatic acids and graphene & GO. Such charge transfer reactions[144] are known to be 
important for predicting oxidative stress potential of ENMs [145] and developing 
biomolecular sensors. 
Although many physicochemical characteristics of ENMs have been reported to 
influence ENM-BC, it is not yet clear what combination of these properties could be used 
to predict ENM-BC formation and evolution [25], [146]. The composition of ENM-BC is 
known to strongly depend on ENM size and surface charge [6], [9], [27], [58], [119], 
[124], [147]–[152].  Larger ENMs exhibit a preferential adsorption of higher molecular 
weight proteins whereas lower molecular weight proteins accumulate more on the surface 
of smaller ENMs. On the other hand, surface charge is expected to be a key factor in 
determining protein structural changes [6], [9], [25], [119], [146], [151], [153]. The 
interactions between ENM surface and proteins could disrupt the structural integrity of 
proteins in ENM-BC and impact their function or elicit adverse immune responses. The 
surface coatings or functional groups are physically and chemically more active relative 
to the core of ENM. For instance, citrate groups adsorbed on the surface of Ag 
nanoparticles (AgNPs) are negatively charged and provide electrostatic repulsion needed 
to prevent AgNP agglomeration. Any oppositely charged biomolecules (compared to 
surface functional groups on ENM) experience a natural electrostatic attraction to adsorb 
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on ENM surface. Proteins with a stronger affinity to the ENM core can quickly displace 
the initially present functional groups and be irreversibly immobilized on ENM surface 
by partial or complete denaturation [25], [119], [154].  A combination of many factors 
including van der Waals forces, hydrogen bridges, charge transfer and other hydrophobic 
interactions are known to drive protein denaturation [155], [156], [11], [157]. Such 
factors naturally depend upon ENM physicochemical properties. It is imperative to 
deconvolute the influence of different physicochemical properties (e.g., surface charge 
and size) and understand how they differ from each other in influencing protein 
adsorption and denaturation in ENM-BC.  
Here, we experimentally investigated the influence of AgNP surface charges on 
adsorption and denaturation of apolipoprotein A-I (ApoA-I). Considering that ApoA-I is 
one of the most abundant proteins in AgNP-BC irrespective of AgNP size [124], its 
adsorption on AgNPs with different surface coatings could provide new insights into the 
role of surface charges in ENM-BC.  ApoA-I is the major protein component of high-
density lipoprotein (HDL). It adopts a shape similar to a horseshoe of dimensions 
12.5x8x4 nm with high α-helix content [53], [158]–[161]. The helices in ApoA-I are 
predicted to be amphipathic, with the hydrophobic (/hydrophilic) face mediating lipid 
(/aqueous) interactions. The thermodynamic drive to minimize the aqueous exposure of 
the hydrophobic residues is one of the major factors in ApoA-I adsorption on AgNPs 
[162], [163]. Our light scattering and surface charge studies on 100 nm AgNPs (with four 
different functional groups) revealed that the binding of ApoA-I on AgNPs is sensitive to 
their surface charge and functionality.  While ApoA-I exhibited a strong affinity for both 
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positively and negatively charged AgNPs, its secondary structure exhibited more 
pronounced changes for two surface functionalities viz., lipoic acid and branched 
polyethyleneimine (bPEI). In this article, we explain the observed secondary structural 
changes in terms of the electronic charge transfer, gleaned from electrochemical cyclic 
voltammetry experiments, between ApoA-I and functionalized AgNPs. Lastly, the 
displacement of positively charged bPEI by ApoA-I and the structural changes of ApoA-I 
on AgNP-lipoic acid were found to induce a significant increase in their ability to 
generate reactive oxygen species (ROS). Our results provide new insights into the role of 
AgNPs surface charge in ENM-BC formation and its influence on bioresponse. 
 
5.2 Materials and methods 
 
Graphene was synthesized using chemical exfoliation technique. Bulk graphite 
(∼1 g) was suspended in 100 mL of N-methyl-2-pyrrolidinone (NMP) and sonicated 
using 1/8” tip sonicator (Branson 250) at 100 W for 2 h. After sonication, the suspension 
was centrifuged at 3000 rpm for 30 mins, and the supernatant was filtered through 0.45 
μm nylon filter and re-suspended in 100 mL of fresh NMP. This fresh solution was 
sonicated again for 6 h and centrifuged at 1500 rpm for 1 hr. The supernatant was then 
vacuum filtered using a 0.45 μm nylon filter. The filtered powder was washed several 
times using deionized water to remove residual NMP and air-dried to obtain exfoliated 
graphene samples. GO was synthesized using the standard Hummer’s method described 
elsewhere[164]. BN powder was obtained from Graphene Supermarket (SKU: BN-
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100G). It should be noted that our infrared spectroscopy studies showed that GO 
contained several functional groups including hydroxyl, carboxyl, and epoxide 
functionalities[164]. All pure amino acids were purchased from Sigma-Aldrich. For 
studying the interactions with amino acids, 100 g of ENMs (graphene, GO, and BN) 
were incubated for 12 hrs in 1 mL solution of amino acids. After incubation, the samples 
were centrifuged at 13,000 rpm and the supernatant was removed. The samples were 
washed thrice to remove any amino acids not adsorbed on ENMs and were finally 
suspended in DI water. For transmission electron microscopy (TEM), the samples were 
suspended on a 400-mesh Cu grid and the TEM images were acquired using Hitachi H-
7600 microscope. Micro-Raman spectroscopy was performed using 514.5 nm Ar+ ion 
excitation coupled to a Renishaw micro-inVia spectrometer equipped with a 50x 
objective and Peltier-cooled CCD. For Raman measurements, the samples were drop 
casted on a microscope slide and were gently air-dried before collecting the Raman 
spectrum. Photoluminescence measurements were obtained using a Horiba-Jobin Yvon 
nanolog spectrometer equipped with a liquid-nitrogen cooled CCD.   
An aqueous solution of AgNPs (100nm, NanoXact, Nanocomposix) with citrate, 
polyvinylpyrrolidone (PVP), branched polyethyleneimine (bPEI) and lipoic acid as 
capping agents were purchased. ApoA-I from human plasma (MW = 28.3KDa) was 
purchased from Sigma-Aldrich. Different ApoA-I concentrations (0-4 g/L) were 
considered with AgNPs (50 μM) to study hydrodynamic size and zeta potential using 
Zetasizer Nano ZS90 (Malvern Instruments). For transmission electron microscopy 
(TEM) characterization of the corona formation, AgNPs with ApoA-I biocorona were 
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stained with 0.1% osmium tetroxide (OsO4) by incubating for 30 minutes. These samples 
were then drop casted on 400 mesh Cu grid and TEM images were acquired using a 
Hitachi H-7600 microscope.  
Electrochemical studies were performed using a Gamry reference 3000 
electrochemical system. Cyclic voltammetry (CV) measurements were obtained in a 
three-electrode setup with Ag/AgCl as the reference electrode, platinum wire as the 
auxiliary/counter electrode. GO, and boron nitride samples were drop casted on a glassy 
carbon electrode (diameter: 3 mm) and air dried for 12 hours. ENMs adsorbed on the 
glassy carbon were used as the working electrode with a high purity Pt counter electrode. 
Stock solutions containing tyrosine, tryptophan, and phenylalanine with varying 
concentrations were prepared in 0.05M PBS solution (electrolyte). For other study, 
AgNPs formed the working electrode. We used ApoA-I solution as the electrolyte to 
study charge transfer. It should be noted that we used concentration ranges based on the 
physiological levels of ApoA-I (~1-1.3 g/L) for electrochemical studies to avoid high 
current values that could result in artifacts in charge transfer measurements.  
Circular Dichroism (CD) measurements were performed using Jasco 
spectropolarimeter (J-810) to analyze secondary structures of ApoA-I after the biocorona 
formation on AgNPs.  Samples were prepared for CD analysis with suspensions of 
AgNPs and ApoA-I corresponding to the molar ratio of 1:600 and incubated at 40 oC for 
8h. The CD spectra were measured at room temperature with a wavelength range from 
200-300nm for all the samples at a scan speed of 50nm/min. Background correction was 
applied with pure AgNP suspension.  
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Reactive oxygen species (ROS) were evaluated using dichlorofluorescein (DCF) 
assay via flow cytometry (by counting 10000 cells per sample). Macrophages were 
grown to 90% confluence and exposed to 30 μg/mL of AgNPs for 1h. All the 
measurements were performed in triplicates.  
 
 
5.3 Results & dicussion 





Figure 5.3.1: Representative transmission electron microscope images for (a) graphene, 
(b) graphene oxide, and (c) BN. (d) Raman spectra for as-prepared graphene (red), 
graphene oxide (green) and boron nitride (blue). The D-band (~1350 cm-1) and the G-
band (~1590 cm-1) for graphene oxide exhibit significant broadening due to the presence 
of defects. Graphene (G-band ~1585 cm-1) and BN (~1366 cm-1) exhibit sharp Raman 
features indicative of good crystallinity.  
 
As shown in Fig. 5.3.1d, graphene and GO exhibited disorder (D-band) and 
graphitic (G-band) bands ~1350 cm-1 and 1581 cm-1 (~1598 cm-1 for GO) respectively. 
The presence of defects in GO, induced during harsh chemical oxidation process in 
Hummer’s method, resulted in a highly intense D-band and a significant broadening of 
the G-band relative to graphene. While graphene samples showed a two-peaked 2D-band 
~2700-50 cm-1 (see Fig. 5.2.1d inset) suggesting it to be few-layered (~5-6 layers), the 
2D band in GO was suppressed due to oxidation. BN sheets exhibited a strong peak 
~1366 cm-1 in their Raman indicating excellent crystallinity similar to graphene.  
Previously, many theoretical studies[143], [165], [166] investigated the 
interactions of aromatic amino acids with carbon-based ENMs such as carbon nanotubes 
(CNTs), graphene, and GO. These studies observed that the aromatic rings of amino acids 
prefer to stack on CNTs and graphene sheets due to the presence of 
interactions[143], [165]. In contrast, it was predicted that GO interacts with 
biomolecules (e.g., proteins, amino acids, nucleobases) through hydrogen-bonding 
interactions[143]. To experimentally validate such predictions, we characterized the 
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amino acid adsorption on different ENMs using isotherms obtained through 
photoluminescence (PL) studies (Fig. 5.3.2). It is well known that aromatic amino acids 
such as tryptophan, tyrosine, and phenylalanine exhibit strong PL when excited by ultra-
violet light[144]. As discussed in the experimental section, we incubated ENMs with 
different concentration of amino acids (within their physiological concentration range 0-
70 m/L) and obtained the isotherms by measuring the PL arising from residual amino 
acids on ENMs after three rounds of washing. Although it is possible to fit the observed 
isotherms to Langmuir-like models, we did not derive any quantitative conclusions 
because many assumptions for Langmuir isotherms are invalid in our case (e.g., the 
irreversibility of adsorption)[167] [58]. Furthermore, the quenching of aromatic amino 
acid PL when interacting with ENMs could lead to incorrect quantitative results. 
Nonetheless, PL data could be used to glean useful qualitative information regarding the 





Figure 5.3.2: Adsorption isotherms for (a) tyrosine, (b) tryptophan, and (c) phenylalanine 
on graphene, BN, and graphene oxide. Graphene oxide showed significantly higher 
adsorption for tyrosine and tryptophan, possibly due to the formation of hydrogen bonds, 





























































However, phenylalanine showed similar adsorption on all 2D materials that were 
relatively independent of concentration.  
 
 
Figure 5.3.3: (a) A graphene sheet containing p-electrons can be viewed as a quadrupole 
(as depicted by green lobes in the lower panel) with a negative charge above and below 
the sheet and a positive charge around the edges. Similarly, the aromatic ring (shown in 
red) in tyrosine, tryptophan, and phenylalanine could be viewed as quadrupoles with 
charge distribution similar to graphene. Amino acids (e.g., tyrosine shown above 
graphene sheet) exhibit either edge-to-face or off-centered (b) stacking due to 
quadrupole-mediated p-p interactions. (c) BN exhibits positive charge (shown in purple) 
above and below the sheet due to the presence of N atoms that pull the electrons away 





Tyrosine exhibited similar adsorption trends for graphene and BN unlike GO 
(Fig. 5.3.2a). As predicted from density functional theory[143], such contrasting 
isotherms are expected due to the formation of hydrogen bonds (H-bonds) in the case of 
GO. Interestingly, the adsorption curves for graphene and BN were similar although the 
-electron cloud is uniformly delocalized in graphene while it is centered near N atoms in 
BN. The delocalized -electron cloud in graphene induces a quadrupole moment with a 
partial negative (/positive) charge above and below (/in-plane) the sheet (see the lower 
panels in Fig. 5.3.3a and b). Tyrosine also exhibits a similar quadrupole with negative 
charges above and below the aromatic ring. Thus, it may be expected that tyrosine prefers 
perpendicular edge-to-face interactions or off-centered parallel stacking in lieu of face-
centered parallel stacking (Fig. 5.3.3a and b). On the other hand, in case of BN, the 
scenario is different because N is a relatively strong electron-withdrawing group that 
polarizes the -electron density away from the core, and thereby reverses the direction of 
the overall quadrupole moment (compared to graphene) by inducing a central area of 
relative electron deficiency and localization of -electrons around N atoms (lower panel 
in Fig. 5.3.3c).  Accordingly, tyrosine may prefer face-centered stacking on BN surface 
(Fig. 5.3.3c). The edge-to-face orientation in the graphene-tyrosine complex (Fig. 5.3.3a) 
involves less active area of interaction and thus should allow more tyrosine molecules to 
stack on graphene as opposed to off-centered stacking. Nonetheless, the adsorption 
isotherms for graphene and BN (which favors only face-centered stacking for tyrosine) 
are similar suggesting that the edge-to-face interactions in graphene could be possibly 
ruled out. In case of GO, as observed in theoretical calculations[143], the hydroxyl group 
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of the phenolic ring in tyrosine may form H-bonds with the hydroxyl groups on GO 
leading to higher adsorption. Returning to Fig. 5.3.2a, we found that the adsorption on 
GO saturated abruptly beyond 15 M/L for tyrosine possibly due to the saturation of 
limited hydroxyl groups on the surface of GO. Furthermore, the formation of H-bonds, 
which necessitates a close proximity between both hydroxyl groups (one from GO and 
another from tyrosine), may also prevent multilayer adsorption in GO.  
Interestingly, tryptophan exhibited a monotonically increasing trend for 
adsorption on GO unlike tyrosine (Fig. 5.3.2b). The hydroxyl groups of GO are predicted 
to form H-bonds with indole ring hydrogen in tryptophan[143]. In addition to the 
H-bonds, tryptophan may exhibit relatively stronger - interactions with GO due to the 
presence of extended -cloud in the indole ring. The adsorption of tryptophan on 
graphene and BN was similar to tyrosine and could be entirely attributed to - stacking 
arising from interactions of quadrupoles induced by -electron cloud (off-centered 















































































































































Figure 5.3.4: (a) Cyclic voltammetry loops for graphene and tryptophan show the 
appearance of a new peak ~0.6-0.8 V indicating irreversible charge transfer. (b-d) Charge 
density isotherms derived from their corresponding CV loops for different 2D materials 
and amino acid combinations. Insets shows zoomed in view of the plot of charge density 
vs concentration for Gr and BN. 
 
There was no significant difference in the adsorption of phenylalanine on 
graphene, BN, and GO. This result is not surprising because the structures of tyrosine and 
phenylalanine differ only by the presence of an extra hydroxyl group. The lack of 
hydroxyl group in phenylalanine (unlike tyrosine) precludes the possibility of H-bonds 
and thereby results in a lower affinity for GO.  The qualitative conclusions, based on PL 
data, were further confirmed using cyclic voltammetry studies discussed later in Fig. 
5.3.4.  
While the PL studies provide insights into physical adsorption and affinity 
through - interactions, the nature of chemical bonding can be understood through 
perturbations in electronic structure. We used cyclic voltammetry and micro-Raman 
spectroscopy to understand the influence of amino acid adsorption on the electronic 
structure of ENMs.  We performed cyclic voltammetry (CV) measurements with ENMs 
as a working electrode in amino acid electrolyte solution (Fig. 5.3.4). In CV 
characterization, the application of gate voltage on the working electrode (i.e., ENMs in 
our case) modulates its electronic energy levels, which when in the vicinity of energy 
levels of the amino acids (present in the electrolyte) can result in a charge transfer.  For 
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quantifying the electrochemical charge transfer, we first obtained a base CV curve with 
0.05 M PBS electrolyte solution containing no amino acids (see Fig. 5.3.4a). 
Subsequently, amino acids aliquots of varying concentrations were introduced into the 
electrochemical cell and scan rate normalized CV loops were obtained for each 
concentration. The total amount of charge-transferred was obtained by integrating the 
area enclosed by the CV curves and subtracting the base area (from the CV curve in 
0.05M PBS electrolyte solution). As shown in Fig. 5.3.4b-d, we found that the charge-
transfer isotherms for all ENMs and amino acid combinations showed clear trends as a 
function of concentration.  
In a typical CV plot, a peak in current (in a current vs. voltage plot such as the one 
shown in Fig. 5.3.4a) or changes in the CV loop area indicate the presence of charge 
transfer between the electrolyte (i.e., amino acid in PBS solution in our case) and the 
working electrode (i.e., ENMs). The changes in CV loop area could occur due to two 
reasons: i) chemisorption or binding of amino acids with ENMs results in an irreversible 
reaction, which appears as a peak in the CV loop (e.g., graphene/tryptophan in Fig. 
5.3.4a) and thereby changes the enclosed area, and ii) physisorption, which decreases the 
available surface area of ENMs for ion adsorption leading to a decrease in the total loop 
area.  
The charge density isotherms (Figs. 5.3.4b-d), obtained from the CV curves, 
show the combined effects of both physi- and chemisorption. We observed that GO 
exhibited the largest changes in charge density suggesting the strong interaction between 
GO and amino acids as observed in PL (cf. Fig. 5.3.2) and previous theoretical results 
 
 97 
[143]. The charge density changes in graphene and BN were significant (see insets in Fig. 
5.3.4b-d) but much smaller compared to GO. It should be noted that the base CV loops 
for GO in pure PBS solution enclose a much larger area (~ 1.75 C/m2) compared to 
graphene and BN (~50-300 mC/m2) due to the presence of quinone, carboxyl, and 
epoxide functional groups. The net reduction of CV loop area for GO in the presence of 
amino acids is a combined effect of physi- and chemisorption. However, CV 
measurements alone cannot distinguish the difference between physical and chemical 
interactions. On the other hand, the micro-Raman spectrum of carbon-based ENMs is 
highly sensitive to charge transfer and may be used to resolve the difference between 
chemical and physical interactions. Carbon-based ENMs exhibit strong Raman features 
such as the G and 2D-bands (cf. Fig. 5.3.1d), which are known to upshift (downshift) 
when any acceptor (donor) species interact via hole (electron) transfer[144]. As 
documented in the literature[168], the peak frequencies and shape of G- and 2D-band 
depend on the Fermi energy (EF) of carbon-based ENMs. In a simplistic picture, an 
upshift (downshift) in EF (or equivalently Fermi velocity) results in a downshift (upshift) 
in G- and 2D-bands. Previously, Rajesh et al. [165] theoretically showed that the EF of 
graphene and CNTs undergoes an overall shift (as large as 0.21 eV) upon interaction with 
amino acids due to charge transfer. Indeed, their study found that the degree of shift in EF 
of ENM-amino acid complexes varied as a function of the polarizability of the aromatic 
moiety of the adsorbed amino acid molecules. In our studies, GO displayed a downshift 
in the G-band frequency (Table 5.3.1 and Fig. 5.3.5a) for tryptophan and phenylalanine. 
It should be noted that the 2D band is absent in GO due to the disruption of the so-called 
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double-resonance Raman process upon the oxidation of graphene lattice[169]. The shifts 
in G-band are expected due to the formation of chemical bonds, as ascertained in the 
reduction in charge density from CV measurements (cf. Fig. 5.3.4). The magnitude of the 
shifts in G-band of GO was highest for phenylalanine concurring with the CV data (Fig. 
5.3.4d). Interestingly, tyrosine (unlike phenylalanine and tryptophan) was found to 
upshift the G-band in GO although a distinct reduction in the charge density was 
observed in CV measurements (Fig. 5.3.4b). Such an observation suggests that the 
physisorption of tyrosine, which may preclude the participation of functional groups on 
GO in electrochemical charge storage, overwhelmed the chemisorption leading to the 






Figure 5.3.5: (a) Raman spectra of graphene oxide-amino acid complexes showed 
significant shifts due to the formation of hydrogen bonds with amino acids. The starred 
peaks arise from tyrosine due to its high Raman cross-section. (b) Raman spectra for 
graphene-amino acids complexes show shifts in G- and 2D-bands (in (b) and (c) 





















































graphene. Solid lines in indicate fits to the experimental data. The red curves in panel (c) 




Table 5.3.1:  The positions of Raman peaks for graphene, graphene oxide, and BN-amino 
acid complexes derived from Fig 5.3.5 
 
Table 5.3.2: The positions of deconvoluted 2D-band for graphene derived from Fig. 
5.3.5c.  
 
In case of graphene, a significant downshift was observed in both G- and 2D-
bands when interacting with tyrosine (Fig. 5.3.5 and Table 5.3.1).  As explained earlier, 
this downshifts in G- and 2D-bands of graphene-tyrosine complex could be understood in 
terms of upshift in EF induced by electron-transfer from tyrosine[165]. Although a 
discernible shift was observed for graphene-tyrosine complex, the widths of G- and 2D-
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band did not change significantly. The presence of chemical interactions between 
graphene and tyrosine (through electron transfer) suggests that the adsorption may 
predominantly be mono- or bi-layered because only the molecules within the vicinity of 
graphene (~0.4-1 nm) can exhibit charge transfer and bind strongly. Based on the Raman 
measurements, it is plausible that the minute changes in charge density (Fig. 5.3.4b) 
resulted solely from chemisorption. On the other hand, tryptophan and phenylalanine 
(Fig. 5.3.5 and Table 5.3.1) resulted in a significant broadening of G- and 2D- bands 
despite little or no shift (i.e., no charge transfer) in the frequency (Tables 5.3.1 and 
5.3.2). It is likely that tryptophan and phenylalanine exhibit multilayer physisorption 
unlike monolayer chemisorption in the case of tyrosine. In such a scenario, the 
multilayers of amino acids could contribute prominently to the non-radiative decay of 
excited electrons, which could, in turn, result in the observed broadening of G- and 2D- 
bands. Interestingly, tryptophan exhibited an increase in the charge density due to the 
presence of a new peak in the CV loop (cf. Fig. 5.3.4a and inset in Fig. 5.3.4c) suggesting 
that both chemisorption and physisorption are involved. 
In case of BN, we did not observe appreciable changes either in CV 
measurements or Raman spectra suggesting the absence of chemisorption. Such a result 
is expected due to the localization of -electrons around N in BN unlike uniformly 










Figure 5.3.6: Transmission electron micrographs showing as-purchased Ag NPs (a-d) 
with citrate, PVP, bPEI and lipoic acid coatings respectively. The presence of biocorona 
(see arrows in e-h) upon incubation with ApoA-I was assessed using OsO4 staining as 
shown in (e-h). Scale bar is 100 nm. 
 
As shown in Fig. 5.3.6, TEM images confirmed that all four types of AgNPs 
(citrate, PVP, bPEI, and lipoic acid coated) are spherical in shape with a similar size ~100 
nm in their dehydrated state. ApoA-I appeared to non-uniformly adsorb on to AgNPs 
(Fig. 5.3.6e-h) with a strong preference for rough edges (see Fig. 5.3.6.f and h).  Given 
the small size of ApoA-I protein (hydrodynamic size ~ 8 nm) relative to 100 nm AgNPs, 
the corona possibly consisted of multiple ApoA-I layers. In some cases, ApoA-I was 
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found to envelop AgNP aggregates in the dehydrated state under TEM similar to previous 
observations [170].  
Although all AgNPs have the same size in their dehydrated size (as evidenced by 
TEM), we found that their hydrodynamic sizes (SHD) differed from each other in the 
following order: bPEI (~135 nm) > PVP (~120 nm)>lipoic acid (~108 nm)> citrate (~100 
nm). This trend is expected based on the size of the surface coating molecules where 
polymers (bPEI and PVP) are significantly larger than the smaller citrate and lipoic acid 
groups. The difference in the surface coatings was also evident from their zeta potential 
() measurements where bPEI is positively charged with a relative low  ~8.89 mV while 
citrate (mV), PVP (mV), and lipoic acid (mV) exhibited larger 
negative values. Based on the zeta potential measurements, negatively charged ApoA-I 
((mV [170]) is expected to display strong electrostatic attraction towards bPEI 
coated AgNPs and possibly experience some repulsion from other negatively charged 




Figure 5.3.7: (a) The hydrodynamic size of AgNPs was found to change with increasing 
ApoA-I concentrations with saturation >2 g/L for AgNP-PVP, citrate, and lipoic acid 
coatings. AgNP-bPEI, however, did not show such saturation. (b) The zeta potential 
measurements showed clear changes indicating the displacement of surface coatings by 
ApoA-I. All surface coatings showed saturation in zeta potential changes >2 g/L 
excepting AgNP-lipoic acid. Based on (a) and (b), it could be inferred that AgNP-bPEI 
and AgNP-lipoic acid do not show saturation in protein adsorption even at high ApoA-I 
concentrations. It should be noted that the physiological concentration of ApoA-I is 1.3-
1.5 g/L.  
 
We studied the evolution of SHD and of AgNPs in the presence of ApoA-I (Fig. 
5.3.7a and b). In case of bPEI, decreased rapidly and changed from a positive to a 
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negative value in the presence of ApoA-I. Indeed, values at higher ApoA-I 
concentrations (~-24 mV) suggest that ApoA-I stabilized AgNPs better than bPEI. A 
concomitant decrease in SHD of AgNP-bPEI suggested that ApoA-I has a higher affinity 
for AgNP surface and ultimately replaced bPEI on AgNP surface. The surface potential 
of AgNP-PVP decreased with increasing concentration of Apo-A1 similar to bPEI. 
However, SHD showed a sharp increase with a rapid saturation at a relatively low 
concentration of ApoA-I (<1 g/L). Unlike AgNP-bPEI and AgNP-PVP, a significant 
increase in SHD for AgNP-lipoic acid was observed only at higher ApoA-I concentrations 
(>2 g/L). The observed changes in both and SHD were much slower for lipoic acid and 
can be rationalized in terms of relatively strong Ag-S interactions (binding energy ~217 
kJ/mol [171]) between sulfur in lipoic acid and the surface of AgNPs. Interestingly, 
AgNP-citrate showed relatively smaller changes in SHD and compared to other surface 
coatings. Nevertheless, in all cases, the increase in SHD did not indicate the formation of 
AgNP aggregates unlike in the dehydrated state. We found that the changes in SHD and 
saturated above 2 g/L for all surface coatings excepting bPEI and lipoic acid. While 
SHD for AgNP-lipoic acid appears saturated, its did not suggest that protein adsorption 
did not saturate.  When the average time between consecutive collisions (c) of ApoA-I 
with AgNPs is greater than ApoA-I configurational relaxation time (R), there is 
sufficient time for ApoA-I to unfold on AgNP surface and thus could form a disorganized 
corona. This condition (c>R) occurs at low ApoA-I concentrations (<2 g/L) for AgNP-
PVP and AgNP-citrate. Indeed, disorganized protein agglomerates can be clearly 
observed on AgNP-PVP surface. However, at higher c ~R, ApoA-I cannot completely 
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unfold due to rapid collisions between ApoA-I and AgNPs. This results in a densely 
packed corona where ApoA-I retains much of its secondary structure. Based on the 
results described in Fig. 2, it may be expected that the corona layer presents directly on 
the AgNP surface is densely packed > 2g/L for all cases excepting bPEI and lipoic acid, 
and thus saturates further changes in SHD and .  The collision frequency (fc=1/c) of 
ApoA-I molecules with AgNP surface may be calculated using the Smoluchowski 
equation [172] 
 
    fc=1/c =2DCdNA    (5.2.1) 
 
where D= 120 um2 s-1 is the room-temperature diffusion coefficient of the ApoA-I [173], 
d= 12.8 nm is the room-temperature hydrodynamic diameter of ApoA-I [174] and, 
NA=6.023 × 10
23 mol-1 is the Avogadro number, and C is the ApoA-I concentration at 
which adsorption saturates. At C= 2 g/L, we find that c ~ 90 s, which is on the same 
scale as protein unfolding timescales.  It should be noted that the value of c derived from 
the above analysis only provides an estimate for the unfolding timescales. Nevertheless, it 
could be used to infer that ApoA-I molecules will collide on a timescale of few tens of s 
at physiological concentrations ~1.3-1.5 g/L, leading to a rapid saturation in adsorption 
[175]. 
 It is well known that some proteins change their conformation upon binding to 
nanoparticle surfaces. Previously, Cukalevski et al. studied the conformational changes 
of ApoA-I on polystyrene (PS NPs) and NIPAM/BAM (N-isopropylacrylamide-co-N-
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tert-butylacrylamide) small sized nanoparticles (<60 nm) with large curvature and 
different surface charges [163]. They found that plain and negatively charged PS NPs 
(diameter ~23-24 nm) slightly increased the helical structure of ApoA-I in the range of 2-
15 % whereas positively charged PS NPs  (diameter ~57 nm) slightly reduced the amount 
of helical structure by ~10%. A similar study by Li et al. on 30 nm negatively charged 
AgNPs and ApoA-I [170] also found a reduction of helical content by ~15-20%. 
Although these previous reports provide some preliminary understanding of ApoA-I 
interactions with ENMs, a controlled study with AgNPs of the same size but different 
surface coatings is necessary to understand the influence of surface change. In this study, 
we used 100 nm AgNPs with different surface coatings to clearly distinguish the effects 
of surface charges and understand the mechanisms involved in ENM-induced protein 
unfolding. In our circular dichroism (CD) studies, we found that ApoA-I exhibited a 
significant decrease in the helical content by >40% on all 100 nm. ApoA-I unfolding is 
more pronounced in our case due to the large AgNP size compared to previous studies 
[163], [170]. The CD spectra revealed that the changes in helical content were more 
prominent for AgNP-bPEI and AgNP-lipoic acid compared to PVP and citrate coatings. 
Indeed, the helical content of ApoA-I may be completely suppressed for these AgNPs 
(Fig. 2.2.1). These changes were accompanied by a concomitant increase in -sheet and 





Figure 5.3.8: (a) Cyclic voltammetry scans showed the appearance of a peak (blue 
arrows) for AgNP electrodes in ApoA-I electrolyte suggesting the presence of charge-
transfer stabilizing interactions. The peak for AgNP-bPEI occurred only in the forward 
scan (going from -0.4 to 0.8 V) indicating irreversible charge transfer. A valley (red 
arrows), the representative of reversible charge transfer, was observed for other surface 
coatings on the reverse scan (0.8 to -0.4 V). (b) The total charge enclosed by the CV 
curves in (a) displayed clear increasing trends with ApoA-I concentration confirming that 
the charge-transfer occurs due to interactions between ApoA-I and AgNPs.  
 
 As shown in Fig. 5.3.8, we performed cyclic voltammetry (CV) to develop a 
mechanistic understanding of surface charge dependent conformational changes observed 
in CD spectra (Fig. 2.2.1). Proteins interact with ENM surfaces through intramolecular 
bonds, ionic bonds, and charge transfer [156], [157]. A stabilizing charge may be 
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transferred between proteins and ENM surface depending upon their electronic energy 
levels, and the adsorbed proteins may undergo various conformational changes during the 
electron exchange process. Charge transfer processes and the relative differences between 
electronic energy levels of protein and ENM surface could be ascertained through peaks 
in current (i.e., charge flow) during a CV scan [58], [172].  
 In the CV scan of AgNPs without ApoA-I (dashed lines in Fig. 5.3.8a), we did 
not observe any peaks for all four surface coatings. The addition of ApoA-I to the 
electrolyte resulted in a change in voltammetric responses with the appearance of a new 
peak (blue arrows in Fig. 5.3.8a), which in turn increased the current considerably. This 
new peak cannot be attributed to desorption of adsorbed hydrogen (which is known to 
occur ~990 mV vs. Ag/AgCl electrode [172]) as the peak appeared at appreciably low 
potentials < 350 mV for all the coatings. We attribute this peak to stabilizing electron 
transfer between ApoA-I and AgNP surface. The electron transfer occurs only when the 
electronic energy levels of ApoA-I are in the vicinity of AgNPs energy levels. The so-
called Fermi energy (EF) or the chemical potential of AgNPs (that serve as the working 
electrode in our CV measurements) is decreased (/increased) when the voltage in a CV 
scan is increased (/decreased).  An electron transfer occurs when the energy levels of 
ApoA-I match the altered EF of AgNPs at a particular voltage in the CV scan. This peak 
voltage for electron transfer was found to be much lower for AgNP-bPEI and AgNP-
lipoic acid (~60 mV) compared to AgNP-citrate and AgNP-PVP (~300 mV) suggesting 
that the surface coatings have considerable influence of electron transfer reactions 
between ApoA-I and AgNPs (Fig. 5.3.8a). The surface coatings have different electronic 
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nature relative to each other and may lead to charge transfer peak at different potentials. 
The electrochemical charge transfer (Q) can be quantified by calculating the area 
enclosed by CV curves (Fig. 4a). We found that all the AgNPs showed an increase in Q 
with increasing ApoA-I concentration concurring with our hypothesis that the observed 
peak arises from electron transfer between ApoA-I and AgNPs. The normalized areal 
charge density (Q/cm2) at higher ApoA-I concentrations showed the following trend: 
AgNP-PVP>AgNP-citrate>AgNP-lipoic acid>AgNP-bPEI. This trend appeared to match 
the changes in CD spectra described earlier in Fig. 2.2.1.  
 An interesting feature in the CV scans was the presence of an irreversible charge 
transfer peak for AgNP-bPEI. For bPEI coating, a peak was observed only when the 
voltage was increasing in the CV scan indicative of irreversible charge transfer. On the 
other hand, CV scans for AgNP-citrate, AgNP-PVP, and AgNP-lipoic acid exhibited an 
observable valley (see red arrows in Fig. 5.3.8a) during the reverse voltage sweep 
suggesting that the observed Q for these coatings does not entirely result from 
irreversible charge transfer reaction. This reversible peak may possibly be attributed to 
the formation of hydrogen bonds between ApoA-I and surface coatings (PVP, citrate, and 
lipoic acid). Given that bPEI showed completely irreversible stabilizing charge transfer, 
we expect greater conformational changes in ApoA-I. In other words, the loss of ApoA-I 
secondary structure on bPEI coated AgNPs precludes reversibility of charge transfer. 
Such an observation suggests concurs with the CD spectra, which showed complete loss 
of helical content in bPEI coatings. It could be expected that the disruption of 
stabilizing hydrophobic interactions in the interior of the protein results in an irreversible 
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charge transfer and ensue in ApoA-I structural relaxation on AgNP-bPEI. On the other 
hand, AgNP-PVP and AgNP-citrate facilitate hydrogen bond formation with substantial 
retention of the helical content. Returning to Fig. 2.3.1, the loss in -helical content of 
ApoA-I on AgNP-lipoic acid cannot be explained based on charge transfer. It is possible 
that the ApoA-I molecule unfolds on AgNP-lipoic acid surface to increase its interaction 
with AgNP surface in order to break strong Ag-S interactions in AgNP-lipoic acid.  
 
Figure 5.3.9: DCF assay was used to evaluate the ability of AgNPs with (+Apo) and 
without (-Apo) ApoA-I corona to generate reactive oxygen species (ROS). AgNP-bPEI-
ApoA-I displayed a significant increase in ROS generation compared to AgNP-bPEI 
while the response to AgNP-lipoic acid-ApoA-I was significantly higher than the control. 
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These changes may be attributed the protein unfolding observed in AgNP-bPEI and 
AgNP-lipoic acid.  
 We assessed the ability of AgNPs with and without ApoA-I corona to generate 
intracellular ROS by RAW 264.7 macrophages after 1 h exposure using DCF 
fluorescence assay.  As shown in Fig. 5.3.9, we did not observe any significant changes 
(relative to control) in ROS generation for pristine AgNPs without ApoA-I corona 
irrespective of their surface coatings. However, we found that the addition of ApoA-I 
corona changed the response of AgNP-bPEI-ApoA-I relative to AgNP-bPEI without 
corona and AgNP-lipoic acid-ApoA-I relative to the control. Based on our CD and CV 
results, we attribute these changes to the adsorption and unfolding of ApoA-I on AgNP-
bPEI and AgNP-lipoic acid. Additionally, in case of AgNP-bPEI, ApoA-I corona resulted 
in an increased surface charge (accompanied by a change from positive to negative sign) 
and better stability (cf. Fig. 5.3.7b) that could have also been a contributing factor to the 
observed increase in ROS generation. Despite these changes in ROS generation, we did 
not observe any significant differences in the cytotoxicity of AgNPs before and after 
ApoA-I adsorption. Furthermore, our flow cytometry data did not show significant 
changes for AgNPs upon the addition of ApoA-I corona.  Based on these results, changes 
in AgNP dissolution or uptake upon the addition of ApoA-I corona could be ruled out as 








In summary, our dynamic and electrophoretic light scattering studies showed that 
ApoA-I displaces surface coatings such as citrate, PVP, and bPEI even at low 
concentrations (< 2 g/L). In case of AgNP-lipoic acid, strong Ag-S interactions inhibit 
ApoA-I adsorption for concentrations below 2 g/L. Circular dichroism studies showed a 
significant decrease in -helical content for all surface coatings with the complete 
disappearance of helices for AgNP-bPEI and AgNP-lipoic acid. The changes in 
secondary structure concur with the observed charge transfer, measured using cyclic 
voltammetry, between ApoA-I and AgNPs. The unfolding of ApoA-I on AgNP-lipoic 
acid cannot be completely explained in terms of charge transfer. It is plausible that 
ApoA-I unfolds on the surface to lower its free energy and thereby break strong Ag-S 
interactions in AgNP-lipoic acid. Lastly, we found a significant increase in the ability of 
ApoA-I coated AgNP-bPEI and AgNP-lipoic acid to generate reactive oxygen species, 
which can be attributed to changes in surface charge and the unfolding of ApoA-I.  
We have systematically carried out photoluminescence (PL), cyclic voltammetry 
(CV), and Raman measurements to elucidate the nature of interactions of aromatic amino 
acids with two-dimensional materials including graphene, BN, and graphene oxide (GO). 
PL and CV studies revealed that GO interacts strongly with tyrosine and tryptophan via 
H-bonding compared to graphene, which exhibited π−π interactions. We also found 
significant charge transfer between graphene and GO complexes with aromatic amino 
acids, as verified from CV measurements and Raman spectra. BN, on the other hand, did 
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not show considerable chemical interactions with aromatic amino acids due to localized 
π-electron clouds. The adsorption of amino acids was found to alter the potential of 
twodimensional materials to generate reactive oxygen species (ROS). We did not find 
significant changes in the ROS levels for graphene, whereas GO and BN showed 
significant differences, which could be explained on the basis of PL and CV 
measurements. In summary, the presence of functional groups and π−π interactions play a 



















ENVIRONMENTAL IMPACTS OF TWO-DIMENSIONAL MATERIALS 
 
6.1 Introduction 
The recent emergence of two-dimensional engineered nanomaterials (2D-ENM) 
enabled the advancement of electronics, sensors, coatings, water treatment membranes, 
and energy storage and conversion devices.[176]–[178] The unique properties of 2D-
ENMs provide advantages for many environmental applications such as i) 
sorbents/photocatalytic materials for environmental remediation including radioactive 
waste removal [179], [180], ii) next-generation water treatment membranes[181], and iii) 
sensors for real-time contaminant monitoring.[182] As the production and technological 
applications of 2D-ENMs continue to grow in the coming years[183], it is imperative to 
study their environmental interactions for understanding 2D-ENM fate, transport, and 
toxicity in order to mitigate any potential risks.[184] It is likely that the high surface area 
of 2D-ENMs amplifies their environmental interactions relative to other 
nanomaterials.[185] 2D-ENMs discharged into the environment, either from the 
production facilities or at the end of the product lifecycle, will inevitably bind with 
natural organic matter (NOM) in water, sediments, and soils. Drawing from our previous 
studies on the effects of protein binding to ENMs or “protein corona” formation in 
mammalian cells, we hypothesize that the interactions of 2D-ENMs with NOM modify 
their surface through the formation of a biocorona and thereby influence their stability 
and interactions with algae.[164], [186]–[188] 
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The objective of this study is to investigate the interactions of aquatic NOM 
(Suwanee River and Nordic reservoir NOMs labeled as SRNOM and NRNOM) with two 
important 2D-ENMs viz., few-layer graphene and BN.  Graphene and BN are structural 
homologues with differences in -electron cloud distribution (delocalized in graphene 
and localized on N in BN), which present good experimental platforms for studying 2D-
ENM-NOM interactions.[189]  In this study, optical absorption and photoluminescence 
(PL) spectroscopy in addition to electrochemical measurements were used to elucidate 
the nature of interactions between NOM and 2D-ENMs. Graphene and BN were found to 
exhibit a higher affinity for SRNOM, which had more aromatic content than 
NRNOM. The delocalized  -electron cloud in graphene facilitated chemisorption of both 
SRNOM and NRNOM, as evidenced by the electrochemical charge transfer between 
graphene and NOMs. On the other hand, BN exhibited little or no charge transfer with 
both SRNOM and NRNOM. Importantly, the formation of NOM biocorona significantly 
impacted the interaction of 2D-ENMs with algal cells. Particularly, the increased surface 
charge of BN-SRNOM complexes was found to mitigate the adverse effects of BN on 
algal photosynthesis. These results suggest that it is critical to include the effects of 
biocorona for assessing the environmental impact of 2D-ENMs.  
 
6.2 Materials and methods 
 
Graphene and BN platelets were synthesized using chemical exfoliation technique 
described in Ref. [190]. Briefly, graphene/BN platelets were synthesized using the 
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chemical exfoliation technique. Bulk graphite (∼1 g) or BN was suspended in 100 mL of 
N-methyl-2-pyrrolidinone (NMP) and sonicated using 1/8” tip sonicator (Branson 250) at 
100 W for 2 h. After sonication, the suspension was centrifuged at 3000 rpm for 30 mins, 
and the supernatant was filtered through 0.45 μm nylon filter and resuspended in 100 mL 
of fresh NMP. This fresh solution was sonicated again for 6 h, and the centrifuged at 
1500 rpm for 1 hr. The supernatant was then vacuum filtered using a 0.45 μm nylon filter. 
The filtered powder was washed several times using deionized water to remove residual 
NMP and air-dried to obtain exfoliated graphene/BN samples 
Suwannee River and Nordic reservoir NOM (SRNOM and NRNOM) were 
purchased from International Humic Substance Society (IHSS #1R101N and 1R108N) 
while humic acid was procured from Sigma-Aldrich. Graphene and BN platelets were 
incubated in SRNOM and NRNOM for 12 hrs at different concentrations to obtain the 
adsorption isotherms. After incubation, samples were centrifuged at 13,000 rpm and the 
supernatant was removed. Subsequently, these samples were washed thrice with DI water 
to remove any loosely bound NOM.  Zeta potential was measured using a Malvern 
Zetasizer. At least ten measurements were performed for each sample to obtain an 
average zeta potential.  Transmission electron microscopy images were obtained using 
Hitachi H7600 and H9500. The absorbance at 254 nm was monitored using a Perkin 
Elmer Lambda 950 UV/Vis spectrometer to characterize the amount of adsorbed NOM. 
Fluorescence spectra were obtained using a Horiba-Jobin Yvon Nanolog coupled to a 
liquid N2 cooled CCD detector. At least 3 repeats were performed to obtain the average 
absorbance/fluorescence. A standard curve was created using NOM stock solutions to 
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obtain the relationship between absorbance at 254 nm and the NOM concentration. 
Charge transfer was studied using cyclic voltammetry in a three-electrode geometry 
(working electrode: 2D-ENMs, counter electrode-Pt mesh, Ag/AgCl reference, NOM as 
the electrolyte) with a Gamry reference 3000 electrochemical system.  
Chlamydomonas freshwater algae were purchased from Carolina Biosupply 
(#152030) and cultured in soli-water medium (#153760) at room temperature under 300 
foot-candles illumination for 7 days prior to the experiments. The algal photosynthesis 
was studied by monitoring CO2 depletion using a bicarbonate indicator solution (0.2 g of 
thymol blue, 0.1 g of cresol red, in 0.01 M NaHCO3).[191] For CO2 depletion studies, the 
indicator solution was mixed with algae and 2D-ENMs (with and without NOMs; 15, 30, 
and 80 g/ml) solution in an airtight tube.  The algal photosynthesis depletes CO2 in the 
indicator solution (coming from NaHCO3) and thereby alters the pH, which can be 
monitored by optical absorbance at 574 nm. All the studies were repeated at least with 
three different sets of algae to obtain statistically meaningful results. The bright-field 
images of algae with 2D ENMs were obtained using the Axio Imager A1, Zeiss.  
6.3 Results and discussion 
 
As shown in Fig. 6.3.1, graphene (~10-15 layers) and BN (~20-25 layers) 
exhibited sheet-like structure, which is a characteristic of 2D-ENMs. Both pristine 
graphene and BN were found to have a negative surface charge in DI water, as indicated 
by their zeta potentials -45 and -26 mV, respectively (see Table 1). Upon NOM 
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adsorption, the zeta potential of graphene and BN significantly increased suggesting 
better stability due to electrostatic repulsion. The effect of NOMs in improving the 
suspension stability was more pronounced for BN with a markedly higher surface charge 
on BN-SRNOM and BN-NRNOM.  
 
Figure 6.3.1: High-resolution transmission electron microscope images of pristine 
graphene and BN shows a layered structure with ~10-15 layers for graphene and 20-15 
layers for BN. The insets show graphene and BN flakes at lower magnification with 













Graphene + SRNOM -71.42 
Graphene + NRNOM -54.57 
BN -26.38 
BN + SRNOM -69.77 
BN + NRNOM -50.86 
 
Table 6.3.1: Zeta potential values to understand the stability of NOM with 2D materials 
in the aquatic environment. The result shows graphene and BN stabilize the NOM 
suspended water. 
The adsorption of SRNOM and NRNOM was found to follow a Freundlich 
isotherm (Fig. 6.3.2) given by 
         (6.1) 
where qe is the amount of NOM adsorbed on 2D-ENMs, Ce is the total concentration of 
NOM in which Kf (and 1/n) for SRNOM was higher (/lower) than NRNOM (Table 2) 
suggesting that both graphene and BN showed a greater affinity for SRNOM. This 
improved affinity was also reflected in the higher zeta potentials for SRNOM-coated 
graphene and BN (cf. Table 1). Such a result may be partly understood in terms of better 
 interactions[192]–[194] arising from higher aromatic content in SRNOM. NOM is a 
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heterogeneous mixture of a variety of organic compounds, consisting of aromatic, 
aliphatic, phenolic, and quinolinic functional groups with varying molecular sizes and 
properties.[195], [196] The aromatic content in NOM exhibits characteristic fluorescence 
spectra when excited by UV-light. This fluorescence intensity of NOM was previously 
used for qualitatively comparing the aromatic content between different types of 
NOM.[197], [198] Strong fluorescence emission ~450-500 nm was observed for both 
SRNOM and NRNOM when excited at 330 nm. However, the fluorescence emission 
from NRNOM was weaker compared to SRNOM, which could be attributed to its lower 
aromatic content. To further validate the hypothesis that SRNOM exhibits greater affinity 
due to higher aromatic content, the adsorption isotherms of 2D-ENMs with humic acid or 
HA, which has a lower aromatic content (and hence lower fluorescence intensity), were 
measured. As expected, both graphene and BN exhibited significantly lower adsorption 
of HA with much lower Kf values confirming our hypothesis (Fig. 6.3.2).  
 
Figure 6.3.2: Adsorption isotherms of NOM on (a) graphene and (b) BN showed that 
Suwanee River NOM (SRNOM) exhibited higher affinity relative to Nordic reservoir 
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NOM (NRNOM) and humic acid (HA) that have lower aromatic content. The solid lines 
are fits obtained using Freundlich equation. Fitting parameters are listed in Table 6.3.2.  
 Kf 1/n 
Gr -SRNOM 0.72 0.95 
Gr – NRNOM 0.41 1.63 
Gr – Humic acid 0.51 0.39 
BN – SRNOM 0.22 1.8 
BN – NRNOM 0.13 2.24 
BN – Humic acid 0.07 1.88 
 
Table 6.3.2: Freundlich adsorption model parameters for graphene, BN with NOMs. 
NOM adsorption on many porous materials is strongly influenced by the physical 
structure of the adsorbent.[199] Although a porous adsorbent (e.g., activated carbon) may 
have a high affinity for the NOM, its adsorption capacity could be limited by the 
accessible surface area because larger molecules in NOM are often blocked by 
micropores and some mesopores[200]–[202]. In such cases, the relationship between Kf 
and 1/n is not linear. In case of graphene and BN, however, it was observed that Kf and 
1/n are inversely proportional (see Table 6.3.2) suggesting that NOM adsorption on 2D-
ENMs is only weakly influenced by their physical structure.   
While  interactions play an important role in the adsorption of NOMs on 
graphene and BN, an interfacial charge transfer between adsorbed NOM and 2D-ENMs 
can stabilize the 2D-ENM-NOM complexes by decreasing their total energy through 
charge redistribution.  Thus, in addition to the adsorption isotherms, cyclic voltammetry 
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(CV) was performed to study the charge transfer interactions between 2D-ENMs and 
NOM. As described in the experimental section, 2D-ENMs were used as the working 
electrode while NOM dissolved in DI water was used as the electrolyte for CV 
measurements. A typical CV scan is performed by cycling the applied voltage on the 
working electrode (2D-ENMs in our case) between two voltage values while 
concomitantly measuring the current. The voltage values were chosen to be -0.2 and 0.8 
V to avoid the electrolysis of water (see Fig. 6.3.3).  The applied voltage on the working 
electrode upshifts (/downshifts) it's electronic energy levels for negative (/positive) 
voltages. A charge transfer or exchange occurs, between the working electrode and the 
electrolyte, when some electronic energy levels of the working electrode (for example, 
lowest energy level in the conduction band or the highest energy level in the valence 
band) matches either the highest occupied molecular orbital (HOMO) or lowest 
unoccupied molecular orbital (LUMO) energy states of the electrolyte. In a CV scan, a 
peak in the current occurs when there is a charge transfer between the working electrode 
and the analyte (NOM in this case) dissolved in the electrolyte. As shown in Fig. 6.3.3a 
and b, clear irreversible peaks were observed for graphene with both SRNOM and 
NRNOM indicating the presence of charge transfer reactions. On the other hand, no 
prominent peaks were found for BN. Such a result is expected the localization of -
electrons on N atoms in BN precludes charge transfer reactions unlike delocalized -
electron cloud in graphene. Similar behavior of graphene and BN was also observed in 





Figure 6.3.3: Cyclic voltammograms of graphene and BN in (a) Suwanee River NOM 
(SRNOM) and (b) Nordic reservoir NOM (NRNOM): A clear irreversible charge transfer 
peak (indicated by solid arrows) was observed for graphene while BN did not exhibit any 
peaks. The dashed arrows indicate the electrolysis of water in the electrolyte at higher 





Figure 6.3.4: Charge transfer isotherms for Suwannee Rive & Nordic reservoir NOM 
(SRNOM and NRNOM) on 2D-ENMs show that NOM adsorption on graphene involves 
chemisorption, unlike BN. The observed differences between graphene and BN could be 
attributed to the delocalized -electron cloud in graphene that facilitates charge transfer 
with aromatic content in NOM.  
 
For a given NOM concentration, the electrochemical charge transfer can be 
quantified using the difference in the area enclosed by the CV curve for electrolytes with 
and without NOM. As shown in Fig. 6.3.4, CV curves were measured at different NOM 
concentrations to obtain charge-transfer isotherms. The charge-transfer isotherms for all 
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2D-ENMs and NOM combinations showed clear increasing trends as a function of 
concentration. In case of graphene, SRNOM showed higher charge transfer compared to 
NRNOM concurring with the results described in Fig. 6.3.2. It is plausible that higher 
aromatic content in SRNOM promotes charge transfer reactions with graphene, in 
addition to  interactions, to facilitate chemisorption. The isotherms for BN showed no 
significant increase in charge transfer with increasing NOM concentration possibly due to 
insulating nature of BN and weaker  interactions resulting from the localization of -
electron cloud on N-atoms.  
Considering that living organisms in the environment may be exposed to 2D-
ENMs through industrial and research waste, the effects of 2D-ENM-NOM biocorona on 
algal photosynthesis were evaluated[191], [204].  Algae are an important component of 
our environment and ecosystem and contribute ~40% of global biomass. In this regard, it 
is imperative to understand the effects of 2D-ENMs entrained in NOM biocorona on 
algal toxicity. Single-celled algae, Chlamydomonas sp., were used as the model system to 




Figure 6.3.5: (a-c) Algae incubated in graphene, graphene with Suwannee and graphene 
with Nordic. (d-f) Algae incubated in BN, BN with Suwannee and BN with Nordic. The 




Figure 6.3.6: CO2 depletion rate measured at 574 nm (as absorbance peak occurs for 
bicarbonate indicator) for (a) graphene and (b) BN samples at different intervals of time 
upon incubation with algae. 
 
As shown in Fig. 6.3.5, pristine and NOM coated graphene were found to 
aggregate into ~10-100 m clusters in the algal medium. Such large aggregates were not 
observed in case of BN. The algal cells retained their spherical shape when exposed to 
pristine and NOM coated graphene indicating minimal interactions between graphene and 
algae. On the other hand, algal cells appeared oblate with ruptured cell walls when 
exposed to pristine and NOM coated BN. The observed rupturing may be attributed to 
adsorption and uptake of BN through nitrate/nitrite transporters proteins involved in 
nitrate assimilation on the surface of Chlamydomonas[205]. Such algal cell rupture is 
expected to strongly impact their photosynthetic activity. At low concentrations (15 and 
30 g/ml), no significant differences were observed for the rate of CO2 depletion for both 
graphene and BN (pristine and NOM coated).  The rate of CO2 depletion at a higher 
concentration 80 g/ml is shown in Fig. 6.3.6.  The rate of CO2 depletion did not show 
any significant difference for both pristine and NOM coated graphene concurring with 
bright-field microscopy images. However, BN and BN-NRNOM were found to 
significantly decrease the CO2 depletion rate. This could be rationalized in terms of the 
light blocking from the photosynthesis centers due to adsorption of the BN and BN-
NRNOM on algae. Interestingly, BN-SRNOM showed a CO2 depletion rate similar to the 
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control plausibly because of the inhibition of its interaction with nitrate/nitrite 




In summary, the adsorption of NOM was found to increase the surface charge of 
graphene and BN, which led to better suspension stability. Suwanee River NOM showed 
higher affinity for graphene and BN due to a higher aromatic content compared to Nordic 
NOM and humic acid. A clear signature for charge transfer between NOMs and graphene 
was observed in cyclic voltammetry suggesting that chemisorption of NOMs.  The cell 
walls of algae were found to be ruptured upon exposure to pristine and NOM coated BN, 
which could be possibly attributed to interactions between BN and algal surface 
transporter proteins involved in nitrate assimilation. While pristine and NOM coated 
graphene did not result in algal cell rupture or change CO2 depletion rate, BN and BN-










SUMMARY AND FUTURE WORK 
Vast commercial products integrated with nanomaterials have posed pressing 
concerns and need for thorough assessment of nanoparticle toxicity. Eventually, these 
produced goods enter aquatic environment posing threat to aquatic organisms. In this 
emerging field of nanotoxicity, we have presented a study of biocorona variation with 
defects, surface functional groups of nanomaterials and also in the altered physiological 
state. Future direction will further address the ability of carboxylated MWCNTs to 
deliver the antigen or allergen in animal studies, and further investigate the toxicity using 
various methods, as well as the possibility of different surface functionalization to alter 
the immune response in vivo. In addition, future studies should examine efficient methods 
to modify the frequency of defect sites on MWCNTs to improve their capability to bind 
antigen and optimize MWCNT-based drug/antigen delivery systems. 
There still lies action mechanisms that govern nanomaterial toxicity yet to be fully 
uncovered. Some overlooked factors like protein gradient, temperature and its effects on 
the composition of biocorona need to be thoroughly assessed. It will be of great interest 
to understand the implications of nanoparticle-induced cellular toxicity, genotoxicity, 
bioaccumulation etc. Although studies of environmental impacts of ENMs has grown 
exponentially, we still lack a complete understanding of its fate, transport, and toxicity in 
the aquatic environment. Further research studies will enable us to build a predictive 
model for nanomaterial toxicological effects which guides in the selection and potential 




Glossary of acronyms used in the dissertation 
1. ENMs: Engineered Nanomaterials 
2. BC: Biocorona 
3. MD: Molecular Dynamics 
4. CD: Circular Dichroism 
5. TEM: Transmission Electron Microscopy 
6. SEM: Scanning Electron Microscopy 
7. 2D: Two-dimensional 
8. SWCNTs: Single-Walled Carbon Nanotubes 
9. MWCNTs: Multi-Walled Carbon Nanotubes 
10. AFM: Atomic Force Microscopy 
11. RAEC: Rat Aortic Endothelial Cells 
12. ICP-MS: Inductively Coupled Plasma-Mass Spectrometry 
13. NOM: Natural Organic Matter 
14. Gr: Graphene 
15. NPs: Nanoparticles 
16. DOS: Density of States 
17. FTIR: Fourier Transform Infrared Spectroscopy 
18. BSA: Bovine Serum Albumin 
19. PVP: Polyvinylpyrrolidone 
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